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Resumo 
As doenças desmielinizantes, como a esclerose múltipla e a lesão da espinal medula, são 
condições patológicas devastadoras, levando frequentemente a lesão axonal, deficiência 
neuronal e perda de função. Embora as células progenitoras de oligodendrócitos endógenas 
(OPCs) sejam prevalentes nas lesões de desmielinização, estas não são capazes de se 
diferenciarem em oligodendrócitos mielinizantes devido ao microambiente inibitório local. 
Apesar dos esforços para desenvolver novas terapias capazes de restaurar até alguma extensão 
a função neuronal, a regeneração do sistema nervoso central (SNC) continua a ser um desafio 
devido à complexidade dos seus componentes e dos mecanismos subjacentes ao processo de 
desmielinização. 
O transplante de OPCs surgiu como uma terapia viável para promover a remielinização de 
axónios não lesados e em regeneração. Ainda assim, o transplante de OPCs sob a forma de 
suspensões celulares apresenta desvantagens, tais como baixa sobrevivência e baixas 
proliferação celular e diferenciação celulares. Neste sentido, a combinação da entrega de OPCs 
com um biomaterial como suporte pode ser vantajosa, nomeadamente para proporcionar um 
nicho para que as OPCs transplantadas possam sobreviver e diferenciar-se em oligodendrócitos 
mielinizantes. Devido às suas propriedades, os hidrogéis podem ser concebidos para imitar 
fisicamente o tecido nativo, proporcionando um microambiente altamente permissivo para a 
sobrevivência celular e crescimento tecidular. Apesar de vários hidrogéis terem sido 
desenvolvidos para entrega de drogas e células para o SNC, apenas alguns foram explorados 
para entrega de OPCs, entre eles a fibrina. 
Ambos as OPCs e os oligodendrócitos expressam um repertório limitado de integrinas, entre 
elas a integrina α6β1. A interacção entre a laminina-211 expressa no SNC e a integrina α6β1 
tem mostrado desempenhar um papel importante na sinalização dos mecanismos que estimulam 
a formação da membrana de mielina pelos oligodendrócitos. 
Deste modo, o objectivo da presente dissertação consistiu em desenvolver um hidrogel 
capaz de incorporar ligandos sintéticos que se ligam especificamente à integrina α6β1, para 
entrega de OPCs no SNC. Para este efeito, os hidrogéis de fibrina foram funcionalizados com 
péptidos sintéticos com afinidade reportada para a integrina α6β1: (1) o péptido T1 do indutor 
angiogénico CCN1 (GQKCIVQTTSWSQCSKS) e (2) o péptido sintético HYD1 (KIKMVISWKG). É 
esperado que a funcionalização com ligandos para esta integrina melhore a bioespecificidade 
da fibrina para as OPCs, através da promoção da extensão de processos e da formação de 
membrana de mielina num microambiente 3-D. 
O efeito da concentração de fibrinogénio na viabilidade e diferenciação de OPCs em 
hidrogéis 3-D de fibrina foi primeiramente avaliado. Embora a concentração de fibrinogénio 
não tenha afectado significativamente a viabilidade celular, esta revelou um impacto na 
extensão de processos pelas OPCs, um indicador de diferenciação, com géis  de fibrina 
preparados com concentrações de fibrinogénio intermédias de 4 e 6 mg/mL a mostrarem o 
maior número de processos por célula, após 9 dias de cultura. Uma vez que a concentração de 
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fibrinogénio de 4 mg/mL mostrou o melhor desempenho biológico global, esta foi seleccionada 
para utilização nos estudos de funcionalização. 
A funcionalização de fibrina com HYD1, T1, e com uma combinação de HYD1 com T1, que 
se ligam especificamente à integrina α6β1, promoveu a extensão de processos pelas OPCs em 
hidrogéis 3-D de fibrina, sem afectar a formação de membrana de mielina. Uma concentração 
de 5 µM de péptido foi suficiente para aumentar o número de processos por célula após 5 dias 
de cultura, em todos os géis funcionalizados. Além disso, a funcionalização com 5 µM de 
péptidos também levou a valores maiores de comprimento máximo, embora não tenham sido 
encontradas diferenças estatisticamente significativas. Ainda, o aumento da concentração de 
péptido para 10 µM ou 20 µM não levou a um aumento da extensão de processos, 
independentemente do péptido utilizado. Em adição, nenhum efeito aditivo/sinérgico foi 
observado em termos de impacto na extensão de processos com a combinação dos dois péptidos 
(5 µM de cada péptido). 
Os resultados obtidos sugerem assim que os géis de fibrina funcionalizados com ligandos 
para a integrina α6β1 são interessantes candidatos para cultura e diferenciação de OPCs num 
microambiente 3-D, e, finalmente, para utilização como um veículo para a entrega de OPCs  no 
SNC. 
 
Palavras-Chave: Desmielinização, Células progenitoras de oligodendrócitos, 
oligodendrócitos, hidrogéis de fibrina, integrina α6β1, laminina 322, péptidos HYD1 e T1. 
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Abstract 
Demyelinating disorders such as Multiple Sclerosis (MS) and Spinal Cord Injury (SCI) are 
devastating pathological conditions, often leading to axonal damage, neuronal disability and 
loss of function. Although endogenous oligodendrocyte progenitor cells (OPCs) are prevalent in 
demyelinated lesions, they are not able to differentiate into myelinating oligodendrocytes 
(OLs), due to the local inhibitory microenvironment. Despite the efforts made to develop new 
therapies capable of restoring at some extent neuronal function, regeneration of the central 
nervous system (CNS) remains a challenging issue due to the complexity of its components and 
of the mechanisms underlying the process of demyelination. 
Transplantation of OPCs has emerged as a feasible therapy to promote remyelination of 
spared and regenerating axons. Still, transplantation of OPCs in the form of cell suspensions 
presents drawbacks such as low cell survival and poor proliferation and differentiation. In this 
sense, the combination of OPC delivery with a suitable biomaterial-based vehicle may be 
advantageous, namely to provide a supportive niche for transplanted OPCs to survive and 
differentiate into myelinating OLs. Due to their properties, hydrogels may be designed to 
physically mimic the native tissue while providing a highly permissive microenvironment for cell 
survival and tissue ingrowth. Despite several hydrogels have been developed for cell and drug 
delivery into the CNS, only a few were explored for OPC delivery, and among them fibrin. 
Both OPCs and OLs express a limited repertoire of integrins, among them the α6β1 integrin. 
The interaction between laminin-322 expressed in the CNS and α6β1 integrin has shown to play 
an important role in signaling mechanisms that stimulate myelin membrane formation by OLs. 
Therefore, the aim of this thesis was to develop a hydrogel incorporating synthetic ligands 
engaging specifically the α6β1 integrin, for delivery of OPCs into the CNS. For this purpose, 
fibrin hydrogels were functionalized with synthetic peptides with reported affinity for α6β1 
integrin: (1) the T1 peptide of the angiogenic inducer CCN1 (GQKCIVQTTSWSQCSKS) and (2) the 
HYD1 synthetic peptide (KIKMVISWKG). The functionalization with α6β1 ligands was expected 
to improve fibrin biospecificity towards OPCs, by promoting process outgrowth and myelin 
membrane formation, in a 3-D microenvironment. 
The effect of fibrinogen concentration on OPC viability and differentiation in 3-D fibrin 
hydrogels was first assessed, with fibrinogen concentrations ranging from 2 mg/mL to 8 mg/mL 
Although fibrinogen concentration did not significantly affect cell viability, this was found to 
impact OPC process outgrowth, an indicator of differentiation, with fibrin gels prepared with 
intermediate fibrinogen concentrations of 4 and 6 mg/mL showing the highest number of 
processes per cell after 9 days of cell culture. Since the fibrinogen concentration of 4 mg/mL 
showed a better overall biological performance, this was selected for use in functionalization 
studies. 
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The functionalization of fibrin with HYD1, T1, and with a combination of HYD1 with T1, 
specifically binding to α6β1 integrin has shown to promote OPC process extension in 3-D fibrin 
hydrogels, without hindering myelin membrane formation. A peptide input concentration of 5 
µM was sufficient to increase the number of cellular processes per cell after 5 days of cell 
culture, in all functionalized gels. Additionally, functionalization with 5 µM of peptides also 
led to higher values of maximum length, although statistically significant differences in 
maximum length were not found. Still, increasing the peptide input concentration from 5 µM 
to 10 µM or 20 µM did not result in an increase in process extension, regardless of the peptide. 
In addition, no additive/synergetic effect resulted from the functionalization of fibrin with 
the combination of the two peptides (5 µM of each peptide), in terms of their impact on 
process outgrowth. 
The results obtained suggest that fibrin gels functionalized with α6β1 ligands are interesting 
candidates for OPC culture and differentiation in a 3-D microenvironment, and ultimately, for 
use as a vehicle for OPC delivery into the CNS. 
 
 
 
Key-words: Demyelination, Oligodendrocyte progenitor cells, Oligodendrocytes, Fibrin 
hydrogel, α6β1 integrin, Laminin-322, HYD1 and T1 peptides 
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1.1. Demyelinating disorders affecting 
the Central Nervous System (CNS) 
 
 
1.1.1.  Myelination in the CNS 
 
The myelin-membrane formation is a distinctive characteristic of glial cells in 
vertebrates. During the myelination process, maturing axons are wrapped by multiple 
concentric membranous layers of myelin produced either by oligodendrocytes (OLs) in 
the CNS or by Schwann cells in the peripheral nervous system (PNS). The myelin sheath 
enables not only the rapid and accurate conduction of electrical impulses along the nerve 
fiber, but also axonal protection and integrity. Besides, there is a mutual regulation 
mechanism between OLs and axons: during development, glial cells ensure neuronal cells 
survival and determine both axolemma domains organization and axons diameter, while in 
turn, axons provide crucial signals for glial proliferation, survival and differentiation, 
consequently regulating myelin-membrane formation as well. In adult life, myelinating OLs 
are responsible for maintaining axons diameter, axolemma organization and also neuronal 
integrity and function, whereas axonal signals regulate oligodendrocyte progenitor cells 
(OPCs) differentiation into OLs and maintain myelin integrity 
[1]
. 
The myelin membrane is composed of a specific set of lipids and proteins, whose 
assembly must occur at a precise and controlled time and space: the glial cells must associate 
with the axons at the appropriate developmental time, so signaling mechanisms can be 
established to deliver newly synthesised myelin-membrane components to the axon 
[2]
. More 
precisely, proliferative OPCs migrate into the white matter regions, exit the cell cycle and 
undergo differentiation, turning into mature OLs. At this point, they begin to express a 
subset of myelin-associated proteins. The mechanism starts with the OLs process extension, 
followed by targeting and adhesion to axonal receptors. Once this connection is established, 
myelin components are synthetized and taken to the appropriate sites within the sheath, 
axons become wrapped and myelin membrane is finally compacted, where the sheaths are 
almost fused and absent of cytoplasm. Nonetheless, this membrane must be maintained 
throughout adulthood. This is achieved by a continuous turnover of myelin associated to a 
high expression of myelin genes, which continues even after the myelination developmental 
process. 
Myelin is composed by approximately 70% lipid and 30% protein. The lipid composition 
includes cholesterol, phospholipids and glycosphingolipids, while the major proteins 
present in myelin are myelin basic protein (MBP) and proteolipid protein (PLP), but other 
proteins such as myelin-associated glycoprotein (MAG) and myelin/oligodendrocyte 
glycoprotein (MOG) are also present 
[3,4]
. This composition gives it insulating properties, 
which are crucial for rapid and efficient propagation of neuronal impulses 
[5]
. 
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As myelin formation requires the synthesis of both lipids and myelin specific proteins , a 
complex cellular mechanism is required to properly synthesize and localize these components 
[6]
. 
 
1.1.2.  Demyelination mechanisms 
 
A demyelinating disease is any disease of the nervous system in which the myelin sheath 
of neurons is damaged. When this occurs, axons lose their myelin sheaths as a consequence of 
OLs death in the site of primary lesion. Furthermore, OLs also undergo apoptosis at 
considerable distances from the lesion, which leads to the hindrance of action potential 
propagation by surviving axons and, consequently, to the loss of neuronal function. 
The breakdown of the blood-brain barrier (BBB) facilitates the infiltration of macrophages 
and myelin-specific T-cell lymphocytes into the CNS, which attack the myelin-producing OLs. 
As a consequence of myelin debris, both microglia and astrocytes are activated. After clearing 
the debris, macrophages, activated microglial cells and reactive astrocytes work together to 
secrete growth factors, cytokines and matrix metalloproteinases (MMPs), that degrade ECM 
components and increase inflammation. These growth factors and cytokines also activate 
quiescent OPCs, thus increasing their proliferation rate. In addition, OPCs respond to pro-
migratory signals provided by demyelinated axons. As a result of these demyelination events, 
OPCs proliferate and migrate to demyelinated areas, in an attempt to differentiate into 
myelinating OLs to repair the lesion (Figure 1) [7]. 
 
Figure 1. Cellular and molecular events occurring during demyelination. Adapted from: [7] 
 
 
The main diseases associated to demyelination in the CNS are multiple sclerosis (MS), 
stroke and traumatic lesions, including spinal cord injury (SCI) and traumatic brain injury 
(TBI). MS and SCI will be discussed in detail in the next sub-sections. 
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1.1.2.1.  Multiple Sclerosis 
 
MS is the most common nontraumatic disorder of the CNS. It affects around 2.5 
million globally, 0.5 million in European Union and 50 000 in Portugal, being more incident 
in developed countries. MS is a chronic inflammatory demyelinating and degenerative 
disease, affecting mainly young adults and causing progressive and significant disability. 
In addition to motor and sensory deficits, there is cognitive deterioration in as many as 
65% of patients.  
The disease course greatly varies from patient to patient, but it generally presents 
a relapsing/remitting form, in which episodes of acute demyelination and neurological 
dysfunction are followed by remyelination and functional recovery. The breakage of the 
blood-brain barrier leads to the infiltration of macrophages and T-cell lymphocytes, 
which react against cells expressing myelin-specific antigens, i.e. oligodendrocytes. This 
leads to destruction of myelin sheaths, axonal demyelination and, consequently, 
neuronal death [8]. Remyelination occurs spontaneously in the first stages of the disease, 
when the lesions present an acute nature. However, remyelination is commonly 
incomplete or not efficient and chronically demyelinated lesions eventually fail to 
remyelinate. After several episodes, the failure of remyelination leads to augmented 
axonal degeneration and progressive disability [9]. 
The only current treatment for MS consists of FDA-approved medications based on 
anti-inflammatory drugs, which are expected to prevent immune and inflammatory 
episodes during the relapsing/remitting phase of the disease. However, with the disease 
progression and accumulated axon damage, these medications become not effective in 
advanced stages [10]. 
Remyelination of axons is therefore necessary for functional recovery. Proliferation 
and migration of OPCs near MS plaques have been the target of several studies, however 
an inability of OPCs to differentiate has also been reported. This inability may be a result 
of inhibitory mechanisms or loss of axonal function, since axons normally provide 
differentiation signals for OPCs. 
 
1.1.2.2.  Spinal Cord Injury 
 
Globally, it is estimated that around 250 000 and 500 000 people suffer a SCI. There 
is no reliable estimate of global prevalence, but the estimated annual global incidence is 
40 to 80 cases per million. In the United States, there are approximately 12 000 new 
cases per year with an additional 232000–316 000 people currently living with SCI [11]. 
SCI is a result of a lesion caused by a compressive or stretch injury in the spinal cord. 
It presents complex hurdles to regeneration due to the multifaceted nature of inhibition 
conditions that occur to cord parenchyma and stroma after trauma. In addition, 
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from a clinical sight, SCI is aggravated by its heterogeneity in size, shape and extent of 
injury. The primary injury caused by initial mechanical trauma is often followed by 
secondary injury events, in which the lesion extends from grey to white matter and may 
cause blocking of the propagation of action potential along axons [12,13]. This secondary 
lesion includes several related events such as BBB dysfunction, local inflammation and 
axonal demyelination, which eventually end up in neuronal death and breakdown of 
neurological pathways [14]. Furthermore, OLs are very sensitive to SCI injury, thereby 
undergoing both necrotic and apoptotic cells death [15]. 
SCI is well characterized by the development of a glial scar by reactive astrocytes, 
which presents the major hurdle to neuronal regeneration after injury. The glial scar 
associated with the production of neurite outgrowth inhibitors form an inhibitory 
microenvironment, thus preventing neuronal function recovery 
[16]
. 
Current treatments include surgery (when the spinal cord is totally compromised) 
and methylprednisolone administration, however none of them is effective. Ongoing 
therapeutic approaches, including the delivery of neurotrophic factors, antagonists of 
neurite outgrowth inhibitors and modulation of inflammatory response have shown to 
restore some of the lost functionality [11,16]. 
 
 
1.1.3.  The inhibitory microenvironment and remyelination 
failure 
 
Remyelination requires the generation of new mature OLs, which are believed to 
derive from a population of adult precursor cells, often referred to as adult OPCs. 
In response to injury, local OPCs switch from a quiescent to a proliferative and 
responsive phenotype. This involves both changes in morphology and upregulation of genes 
associated with the generation of OLs during development. This is followed by the 
repopulation of the demyelinated area with OPCs. Once recruited, OPCs must differentiate 
into functional OLs. 
However, the adult CNS has a limited regenerative capacity, due to the fact 
that, although endogenous OPCs are prevalent in demyelinated lesions, they are not able 
to differentiate into OLs and remyelinate due to the local inhibitory microenvironment. 
The formation of a glial scar, composed of astrocytes and connective tissue elements, is 
one of the barriers to regeneration of CNS axons. The molecular composition of the scar 
(connective tissue components such as collagen and elastin), the inhibitory molecules 
(tenascin, semaphorin 3, ephrin-B2, slit proteins and chondroitin sulfate proteoglycans) 
released by astrocytes and active microglia, as well as genetic factors, sex and age, are 
all contributing factors for regenerative failure [17,18].
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1.2.  Transplanted OPCs as a source of 
myelin-producing cells 
 
 
1.2.1.  OPC differentiation into myelin-producing OLs 
 
 
OPCs were first identified in the early 80s by Martin Raff and his team as proliferating 
cells that could differentiate both into OLs or type 2 astrocytes, the reason of their original 
name O-2A cells Nonetheless, further studies confirmed that in most of the cases their 
differentiation was associated to an OL fate [19]. 
During development, the first OPCs are originated from the neuroepithelial precursor 
cells (NEPs) from the ventricular zone of the spinal cord. The first wave of OPC production 
starts in the ganglionic eminence and eventually a second and third waves originate from the 
lateral and caudal ganglionic eminences, respectively, giving rise to adult OLs. OPCs then 
migrate to other areas, populating the future brain and ultimately myelinating the CNS [20]. 
The development of myelin-producing OLs involves two interdependent stages. The first one 
is the differentiation of OPCs into OLs expressing markers of differentiation, including 
galactocerebroside (GalC) and myelin basic protein (MBP), while in the second stage, these OLs 
subsequently undergo morphological changes associated with the production of myelin sheaths 
[21]. 
Several intrinsic and extrinsic factors are involved in differentiation of OLs and the major 
ones are summarized in Table I. 
Downstream signaling of transcription factors that lead to increased expression levels of 
Olig1 and Olig2 promotes OPC differentiation into OLs and consequently, myelination of the 
axonal tracts. A factor that controls the formation of oligodendrocytes is platelet-derived 
growth factor (PDGF) (Figure 2). PDGF stimulates the proliferation of OPCs and in its absence, 
OPCs exit the cell cycle and may differentiate into OLs prematurely. Also, this factor avoids 
neural stem cells (NSCs) differentiation in other cell types, such as neurons and astrocytes, 
thereby ensuring an OPC fate [22]. Thyroid hormones, particularly T3, induce proliferation of 
OPCs and promote their differentiation into OLs by triggering cell-cycle exit, thereby enhancing 
the morphological and functional changes involved in their maturation [23]. 
Nonetheless, a balance must be kept between promoters and inhibitors of OL differentiation, 
so it occurs in a controlled time and space fashion [24]. 
In the CNS (Figure 2), myelination is controlled by three main types of signals: axon- derived 
signals (e.g. TNFα), ECM (e.g. Fyn signaling) and soluble factor signals (e.g. IGF-1, PDGF, 
CXCL12, Notch family) and finally, intracellular signaling cascades (e.g. downstream signaling 
from receptors that increase the expression of Olig1 and Olig2) inside myelinating OLs. Both 
positive and negative effects should be considered. The control of myelination by ECM will be 
discussed in detail in the section 1.2.3. 
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Figure 2. Remyelination mechanisms: role cytokines, chemokines, growth factors, transcription 
factors and other proteins in OPCs fate. [25] 
 
 
Table I. Major intrinsic and extrinsic factors controlling the differentiation of OPCs into OLs. Based 
on: [7] 
Extrinsic factors Intrinsic factors 
T3 Triggers cell-cycle exit. Olig1 In response to demyelination, 
promotes the transcription of myelin-
specific proteins. 
PDGF  Withdrawal of this growth factor acts 
on intracellular factors to trigger cell-
cycle exit. 
Olig2 In response to demyelination, 
regulates Nkx2.2 expression. 
IGF-1 Promotes cell-cycle exit and OPC 
differentiation. 
Nkx2.2 - Lineage specification; 
- Promotes the transcription of myelin-
specific genes. 
TGF-β1 Promotes cell-cycle exit and OPC 
differentiation. 
Myt1 Controls the expression of myelin-
specific proteins. 
Sox2 Promotes cell-cycle exit and OPC 
differentiation. 
Fyn* Activates the transcription of myelin-
specific genes. 
  PI3K-AKT1 Activates mTOR (final differentiation 
of OPCs into OLs). 
*discussed in detail in sub-section 1.2.3. 
 
In the adult CNS, new OLs are derived from adult OPCs dispersed throughout both grey and 
white matter and in the subventricular zone (SVZ). Although adult OLs differentiation show 
slower rates of migration and longer cell cycle times, it presents some similarities with 
developmental OLs [8]. It was previously mentioned that when myelin is damaged, local OPCs 
undergo an activation step, thereby switching from a quiescent state to a regenerative 
phenotype. This activation step involves the upregulation of several genes associated with 
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OLs differentiation, including Olig2, NKX2.2, MYT1 and Sox2. OPCs are firstly recruited in 
response to factors released by microglia and astrocytes and start to proliferate. The 
differentiation phase of OPCs into OLs comprises three major steps: developing contact with 
the axons, expressing myelin genes and finally producing a myelin membrane and wrapping it 
around axons [20]. 
 
1.2.2.  Therapeutic effect of OPCs in remyelination 
 
As previously mentioned, OPCs are glial cells that differentiate into myelinating OLs 
during embryogenesis and early stages of post-natal life. However, a number of OPCs remain 
in an undifferentiated state, hence their abundance in the adult brain. 
Since local OPCs cannot differentiate due to the inhibitory microenvironment, 
transplantation of OPCs as emerged as a feasible therapy to promote remyelination of spared 
and regenerating axons. 
Adult OPCs can be induced to proliferate and migrate in vitro by the platelet-derived 
growth factor (PDGF) and fibroblast growth factor (FGF), which are both upregulated during 
remyelination [8]. 
A few studies provided proof-of-principle for clinical glial cell transplantation. Archer et 
al. (1997) performed OPC transplantation into shaking dog pups, with PLP mutations that 
trigger Pelizaeus-Merzbacher disease) and demonstrated the ability of the transplanted OPCs 
to myelinate axons in the demyelinated lesions of these animals. [26] In 2008, Windrem et al. 
studies showed that transplantation of highly enriched preparations of human glial progenitor 
cells into multiple sites in mice carrying mutations in MBP enables widespread myelination 
throughout the CNS and recovery from myelin dysfunction in some cases. The transplanted 
mice also exhibit prolonged survival [27]. 
In a study performed by Keirstead et al. (2005), transplantation of human embryonic 
stem cell (hESC)-derived OPCs into a rat model of SCI resulted in enhanced remyelination and 
improved motor function. However, enhanced remyelination and locomotor recovery were only 
observed when OPCs were transplanted at early time points after SCI (7 days after injury). In 
animals receiving OPCs 10 months after injury, there was no enhanced remyelination or 
locomotor recovery, possibly due to the presence of inhibitory molecules associated to the 
astroglial scar [17]. 
 
1.2.3.  Role of the ECM and OPC integrin receptors in myelin- 
membrane formation 
 
It is known that the interactions between cells and their surrounding microenvironment are 
crucial for cell survival, growth and differentiation. The organization of the ECM in the 
developing CNS is still poorly understood. However, Colognato et al. (2005) studies have shown 
that ECM interactions are relevant for glial cell development [28]. 
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The ECM is a complex association of extracellular molecules, including structural proteins 
(i.e. collagen), glycosaminoglycans (GAGs) and specially glycoproteins such as fibronectins 
and laminins, which activate intracellular signal pathways through interactions with integrins 
[29]. 
Integrins are transmembrane protein receptors that bind to ECM proteins, thus mediating 
cellular adhesion and signalling cascades between the extracellular and intracellular 
environments. When a ligand binds to the extracellular domain of a specific integrin, integrin 
clustering occurs and the actin filaments as well as signalling proteins are recruited to the 
intracellular domain of the integrin. 
Integrins structure is heterodimeric, thus consisting of two different chains, α and β 
subunits. The α chains are responsible for determining ligand specificity, while β subunits 
have a cytoplasmatic tail that can bind to several intracellular anchor proteins, such as 
talin, α-actinin and filamin. These anchor proteins can then bind to actin, thus allowing the 
actin association to integrins, which leads to integrin clustering and consequently, to the 
formation of focal adhesions between cells and the ECM 
[30,31]. 
Integrins have been demonstrated to be important for myelination. OPCs and OLs express 
a limited repertoire of integrins, including αvβ1, αvβ3, αvβ5, αvβ8 and particularly the 
laminin receptor α6β1 integrin. Each one of these integrins is regulated and expressed 
depending on the differentiation stage since they play different roles in development: αvβ1 
promotes migration, αvβ3 proliferation, αvβ5 differentiation and α6β1 differentiation and 
survival of new formed OLs [32]. Moreover, α6β1 integrin has shown to enhance cell survival of 
myelinating oligodendrocytes and promote myelination of axonal tracts in vivo [17,33,34]. 
It has been previously referred that upon differentiation into OLs, OPCs undergo a 
phenotype switch, characterized by a dramatic change of morphology and the formation of a 
large network of branching processes. When OPCs exit the cell cycle in order to differentiate 
into myelinating OLs, the survival of these developing cells depends on the contact with axonal 
receptors and on the effect of soluble factors, such as PDGF and neuroregulin-1 (NRG-1). While 
these factors act as mitogens and inhibit differentiation at earlier stages of development, 
upon OL maturation they are fundamental for cell survival and differentiation. Hence, the 
same factors that stimulate proliferation and hinder differentiation may become crucial for 
survival, by switching their phenotype at the precise time and space where OLs undergo final 
stages of differentiation. Although the mechanisms underlying this switch are still not well 
understood, they are thought to be regulated by interactions between integrin receptors and 
ECM ligands [35]. But how do receptors transmit signals from the ECM to OPCs in order to change 
their phenotype? 
Several downstream effectors and pathways may be involved in ECM signaling for myelin- 
membrane formation, including Src Family Kinases (SFKs), small Rho GTPases, Focal Adhesion 
Kinase (FAK), ILK and the phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein 
kinase (MAPK)/Extracellular Signal-Regulated Kinases (ERK) pathways (Fig. 3). 
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Figure 3. Integrins, adaptor proteins, and signaling pathways. [36] 
 
The signaling cascade begins with integrins and other ECM receptors connecting to the 
downstream pathways through SRKs. SRKs are non-receptor tyrosine kinases tethered to the 
inner side of the cell membrane that play an important role in the transduction of external 
signals into changes in intracellular signaling. 
Both Fyn and Lyn belong to the SRKs family and regulate integrin-guided pathways. Lyn 
associates with the PDGFR-αvβ3 integrin complex and its activation contributes to the 
proliferation of OPCs. On the other hand, OPC differentiation into OLs depends on Fyn. Fyn is 
expressed throughout the brain and particularly highly expressed in OLs and its activation and 
expression levels are upregulated during the final stages of differentiation. It is activated by 
signals triggered by laminin through integrins (particularly α6β1) [37,38]. 
SRK pathways regulate the activation of Rho GTPases (e.g. Rho, Rac and Cdc42) through 
Fyn (Fig. 4). After differentiation, Fyn phosphorylates and activates p190RhoGAP, which then 
inactivates Rho activity, thus causing modifications in OL morphology. Furthermore, Fyn 
activates both Cdc42 and Rac, which promote differentiation of OLs. Rho GTPases, either 
through activation or inactivation, regulate the polymerization of actin, and consequently 
control cytoskeleton structure and cellular motility [39]. 
FAK is activated in differentiating OPCs and, such as Fyn, it also integrates signals from 
the ECM, inducing cytoskeleton changes that ultimately contribute to myelination. Both Fyn 
and FAK pathways mediate laminin interactions with the cytoskeleton. 
Laminins are heterotrimeric proteins of the ECM that consist of a α-chain, a β-chain and a 
-chain. The trimeric proteins form a cross-like structure that can bind to other cell membrane 
and ECM molecules, thereby playing an important role in cell adhesion, migration, proliferation 
and differentiation [40]. Laminins are found in myelinating axon tracts stimulating soluble 
factors such as PDGF and NRG [38]. 
The interaction between laminin-211 expressed in the CNS and oligodendrocyte α6β1 
integrin has shown to play an important role in signaling mechanisms that enhance the 
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morphological changes, stimulating the myelin membrane formation by OLs [34]. Studies from 
Buttery and ffrench-Constant (1999), Relvas et al. (2001) and Colognato et al. (2004) have 
shown that laminin-integrin interactions affect oligodendroglial process extension in both 
length and branching [20,33,38]. Moreover, in a study performed by Zhao et al. (2009), laminin 
was reported to re-appear in demyelinated lesions that are starting to repair. Laminins 
potentiate the ability of newly differentiated OLs to survive at limited quantities of trophic 
factors. On the other hand, fibronectin was shown to reduce the ability of OLs to form 
branched processes by stimulating OPCs to continue to proliferate [28]. 
 
Figure 4. Integrin regulation of Rho-GTPases during stages of cell spreading and process outgrowth. 
[41]
 
The previously referred Fyn pathway is also required to enhance PDGF signaling to promote myelin-
membrane formation and to change NRG signaling course from a PI3K to a MAPK pathway, this way 
changing the development stage from proliferation to differentiation. PI3K is thus activated by NRG-1 
type III produced by naked axons, subsequently activating the PI3K-AKT1 pathway by growth factors 
and ECM molecules. This pathway will eventually induce differentiation of OPCs into myelin-producing 
OLs, as well as cytoskeleton reorganization [42]. In a study from Colognato et al. (2002), the activation 
of ERK1 and ERK2 was enhanced as a response to NRG when OLs were cultured on laminin-2 [38]. 
Therefore, besides enhancing survival, MAPK/ERK signaling has shown to promote process extension 
and differentiation of OLs. Furthermore, it has revealed that a switch from a PI3K-dependent to a 
MAPK-dependent signaling is necessary in order to promote differentiation. 
 
1.2.4. The cytoskeleton in myelin-membrane formation 
 
During OL development, signals relevant to process formation mus t be transduced into 
adequate changes in cytoskeletal organization. OPCs have a bipolar morphology, however, as 
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the OLs mature, they become multipolar through the extension of several processes that 
eventually extend many orders of branches. Therefore, OL cytoskeleton plays an essential 
role on their interaction with axons and also in the regulation of branching and process 
outgrowth [44]. 
OLs present a complex cytoskeleton architecture, which is characterized by an organized 
and dynamic network of microtubules and microfilaments, however absent from intermediate 
filaments. Myelin-constituting proteins were shown to be involved not only in OL 
differentiation, but also in process extension. In 2006, Galiano et al. reported MBP as a 
microtubule-stabilizing protein in OLs undergoing differentiation [45]. Furthermore, 2’-3’- cyclic 
nucleotide 3’-phosphohydrolase (CNP) was associated to process outgrowth by 
copolimerization with tubulin [46]. 
Microtubules are polarized dynamic structures which are formed by the polymerization of 
heterodimeric complexes of α-tubulin and β-tubulin. Microtubule growth and integrity are 
regulated by microtubule-associated proteins (MAPs) that bind to the microtubules through 
tubulin domains. Several MAPs can be found in OLs, including MAP1B, MAP4, MAP2c and tau 
proteins. The latter are specifically present at branching areas and ends of the cellular 
process extensions. Upon differentiation, there is a decrease in tau phosphorylation, enhancing 
their binding to microtubules.  
Also Fyn kinase interacts with OL cytoskeleton by coupling with tau and tubulin, thus 
contributing for the initiation of process outgrowth and myelination. Moreover, The OL 
morphology during differentiation may occur via ECM pathways from integrins to Fyn and 
finally, to Rho GTPases, which leads to the formation of the motility structures referred [45]. 
In Figure 5, it is possible to observe the differences in branching and process outgrowth 
associated with different stages of differentiation (OPCs and OLs). 
 
 
Figure 5. Immunocytochemical localization of microtubules and MBP during OL differentiation. 
OPCs (a-c) and OLs cultured for 6 days in vitro (d-f) derived from rat brain can be observed. 
Immunofluorescence with antibodies against tubulin (a,d) and MBP (b,e). Nuclei stained with DAPI and 
merged with tubulin (red) and actin (green) staining(c,f). Scale bar=25 µm. [44] 
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1.3.  Vehicles for OPC delivery to the CNS 
 
1.3.1.  Overview 
 
 
Despite being a source of potential myelin-producing cells, transplantation of OPCs by 
direct injection of cell suspensions presents drawbacks such as low cell survival and poor 
proliferation and differentiation [43]. This is mainly due to the lack of mechanical and 
biochemical support associated to the inhibitory microenvironment generated either by the glial 
scar or the inflammation mechanisms occurring upon demyelination [8]. Tissue engineering 
provides an alternative approach to overcome these limitations and thus increase the efficacy of 
OPC transplantation therapies in the CNS, namely by combining cellular transplantation with 3-
D biomaterial based-vehicles. These 3-D matrices may protect transplanted cells from the local 
hostile tissue environment, thereby creating a supportive niche for OPC survival, proliferation 
and differentiation. 
 
 
1.3.2.  Hydrogels as vehicles for OPC delivery into 
demyelinated lesions 
 
 
Cells can sense and respond to the biophysical properties of the microenvironment through 
mechanotransductional mechanisms. In particular, adhesion ligands binding to integrins and 
other cell surface receptors, serve as mechanical transducers between the surrounding 
environment and the cytoskeleton [44], allowing cells to sense and respond to matrix stiffness. 
The stiffness of the matrix affects cell spreading, morphology and function, and generally, cells 
show better in vitro behavior when cultured in matrices with mechanical properties similar to 
those of their native microenvironment. 
Therefore, apart from being biocompatible and biodegradable (by cell-secreted proteolytic 
enzymes, ideally) the engrafted biomaterials should have mechanical properties closely 
matching those of the target tissue. 
Hydrogels have proven to fulfill these requirements, as these can be prepared to present 
different stiffnesses (by varying the polymer concentration and the cross-linking degree). 
Furthermore, hydrogels are hydrophilic polymer networks with high water content (similar to 
the ECM) and high permeability, allowing exchange of oxygen, nutrients and metabolites, 
thus providing a highly permissive microenvironment for cell survival and growth. Finally, 
hydrogels can be decorated with biochemical or biophysical cues (cell adhesive or growth factor 
binding ligands) to better mimic the native ECM [34]. 
In situ forming hydrogel systems are of particular interest in tissue engineering applications. 
Injectable hydrogels are likely the most investigated materials for local drug and cell delivery to 
the CNS. It was previously referred that hydrogels already present a set of advantages that make 
Introduction 
 
14 
them suitable for these applications. In addition, injectable hydrogels have the ability to provide 
a minimally invasive, localized and filling platform for therapeutic purposes. Upon injection into 
the spinal cord tissue, these polymers undergo a rapid transition from liquid to gel phase, 
thereby adapting to the specific lesion site and ultimately integrating with the native tissue. 
Also, like any hydrogel-based scaffold design for the CNS, injectable hydrogels can be 
formulated to present mechanical properties closely matching those of the spinal cord ECM. [47]. 
A list of hydrogels used for neural tissue engineering is presented on Table II. The 
mechanism of gelation is indicated and the main advantages/disadvantages discussed. 
 
Table II. Hydrogels used for neural tissue engineering: mechanisms of gelation and advantageous (+) and 
disadvantageous (-) characteristics. Adapted from: Li X. et al. (2012) [48] 
 
Hydrogel Gelation mechanism Advantages and disadvantages 
Polyacrylamide Chemical crosslinking Adjustable mechanical properties 
(+) 
Control of architecture and 
chemical composition (+) 
Non-immunogenic (+) 
Non-biodegradable (-) 
Non-permissive (-) 
Neurotoxicity (-) 
NeuroGelTM 
poly[N-2 
(hydroxypropyl)methacrylamide] 
(PHPMA) gel modified with a RGD 
sequence[49] 
Chemical crosslinking Biocompatible (+) 
Non-immunogenic (+) 
Mechanical properties (+) 
Non-citotoxicity (+) 
Non-biodegradable (-) 
PEG [50] Photocrosslinking; 
chemical crosslinking 
Highly biocompatible (+) 
Non-immunogenic (+) 
Neuro-protective (+) 
Highly hydrophilic (-) 
Non-biodegradable (-) 
Modified PEG (with poly(lactic  
acid) (PLA) and poly(glycolic  
acid) (PGA))[51] 
Photocrosslinking; 
chemical crosslinking 
Highly biocompatible (+) 
Non-immunogenic (+) 
Neuro-protective (+) 
Biodegradable (-) 
Highly hydrophilic (-) 
Collagen [52] Chemical 
crosslinking  (pH,  temperature 
and 
ionic strength sensitive) 
Highly biocompatible (+) 
Injectable (+) 
Enzymatically degradable (+) 
Possibly immunogenic (-) 
Weak mechanical properties (-) 
Fibrin [53] Enzymatic crosslinking Highly biocompatible (+) 
Injectable (+) 
Chemical modifiable (+) 
Incorporation  of  bioactive  
signaling molecules (+) 
Enzymatically degradable (+) 
HA [54] Chemical crosslinking Highly biocompatible (+) 
Injectable (+) 
Non-immunogenic (+) 
Enzymatically degradable (+) 
Chemically modifiable (+) 
Highly hydrophilic (-) 
Agarose [55] Thermosensitive Injectable (+) 
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Non-neuronal permissive (-) 
Lacking of cell binding domain (-) 
Non-naturally  enzymatically  
degradable (-) 
Alginate [56] Ionic crosslinking Easy crosslinking (+) 
Injectable (+) 
Inhibition of protein adsorption (-) 
Non-enzymatically degradable (-) 
Chitosan [57] Ionic  (polyanions)  and/or 
chemical 
crosslinking, 
thermosensitive 
Highly biocompatible (+) 
Easy modification (+) 
Injectable (+) 
Enzymatically degradable (+) 
Only soluble in dilute acid (-) 
Inflammatory response (-) 
Methylcellulose [58]  Thermosensitive Injectable (+) 
Limited protein adsorption (-) 
Non-enzymatically degradable (-) 
Matrigel ® [59] Thermosensitive Injectable (+) 
Highly biocompatible (+) 
Enzymatically degradable (+) 
From mouse tumor cells (-) 
Immunogenic (-) 
Doubt about exact composition (-) 
Polysialic acid (PolySia)-based 
Hydrogels [60] 
Diepoxyoctane crosslinking Bioresorbable (+) 
Non-immunological (+) 
Highly specific degradation (+) 
Xyloglucan 
[61] 
Thermosensitive Injectable (+) 
Difficult production (-) 
Enzimatically  degradable  by  
glycoside hydrolases (GH) 
Peptide hydrogel: 
- PuraMatrixTM 
(Peptide RADA 16) - β-sheet 
forming ionic selfcomplementary 
peptide [62] 
- Self-assembling peptide  
amphiphile (PA) [63,64] 
pH, temperature and 
ionic strength sensitive 
Injectable (+) 
Highly biocompatible (+) 
Low mechanical properties (-) 
 
Although hydrogels have already been used for cell delivery to the CNS [30], at the best of 
our knowledge, only two studies using hydrogels for OPC delivery into the CNS were reported 
to date. Li et al. (2013) developed an injectable biocompatible hydrogel based on thiol- 
functionalized hyaluronic acid (HA-S) and thiol-functionalized gelatin (Gtn-S), which were 
crosslinked by poly-(ethylene glycol) diacrylate (PEGDA). Transplant of OPCs within these 
hydrogels showed enhanced survival and differentiation into OLs, as well as the ability to 
remyelinate demyelinated axons [65]. In the same year, Asmani et al. performed the first study 
reporting fibrin hydrogels as a suitable 3-D support for culture and differentiation of OPCs 
derived from endometrial stromal cells, which not only allows cell-cell interaction, but also 
mechanical stimulation similar to that of ECM. This study will be discussed in detail in the 
section 1.4.2. [66]  
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1.4. Fibrin hydrogels as versatile vehicles 
for cell delivery 
 
1.4.1. Fibrin structure 
  
Fibrin is a FDA-approved hydrogel with widespread clinical use since it was first purified in 
large quantities in the 1940s. Due to its role in hemostasis and wound repair, fibrin has been 
used extensively in hemostatic materials, such as fibrin sealants (known as fibrin glue) and 
wound dressings [67]. 
As a naturally occurring clotting agent in human body, fibrin is biocompatible and 
susceptible to proteolytic degradation mediated mainly through plasmin and MMPs. In addition 
to its important role in hemostasis, fibrin serves as a provisional matrix for tissue repair 
following injury, constituting a key regulator of wound healing. 
Fibrin sealants include fibrinogen (fibrin zymogen form) obtained from human pooled plasma 
by cryoprecipitation of fresh-frozen plasma or stored plasma [(Tisseel and Artiss (Baxter) and 
Evicel (Johnson & Johnson)] as well as bovine thrombin containing CaCl2 and antifibrinolytic 
agents (aprotinin) [68]. 
Additionally, fibrin can be prepared from the patient’s own blood and used as an 
autologous scaffold without the potential risk of foreign body reaction and infection or, 
alternatively, from recombinant fibrinogen and thrombin [68]. 
Fibrin may thus be obtained from fibrinogen polymerization by the serine protease 
thrombin and then cross-linked by factor XIIIa in the presence of calcium chloride (CaCl2) to 
form a protein mesh. 
Fibrinogen molecules, the circulating precursors of fibrin monomers, are dimeric 
glycoproteins consisting of two sets of polypeptide chains, Aα-, Bβ- and , which are bound 
together by disulfide bridges (Fig. 6). Each molecule contains two outer D domains and a central 
E domain, connected to each other by a coiled-coil segment. 
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Figure 6. Scheme representing fibrinogen structure, its conversion to fibrin and thrombin-mediated 
conversion of the factor XIII to XIIIa. [69]  
 
During the coagulation process, polymerization of fibrinogen molecules, which will eventually 
originate fibrin, initiates when thrombin cleaves the fibrinopeptide A (FPA) from fibrinogens 
Aα-chains. Associations between D and E domains allow the formation of double-stranded fibrils, 
that together with branching processes, form a clot-like network. This assembly promotes 
antiparallel alignment of -chain regions, which are covalently crosslinked into - dimers by the 
plasma transglutaminase IIIa (active form of factor XIII), in the presence of CaCl2 (Figure 6). 
The inactive form, factor XIII, circulates in the blood with fibrinogen and becomes activated 
by thrombin cleavage. The factor XIIIa then stabilizes the fibrin gel by crosslinking of glutamine 
residues within the fibrin network to lysine residues , thereby forming the 3-D protein network 
referred above. Cells can then be directly embedded in the 3-D network upon gel formation. 
The properties of fibrin hydrogels can be controlled by two main variables. The first one is 
the concentration of fibrinogen and thrombin, which affect the fibrin network structure and 
mechanical properties of the gels obtained. Normally, when the fibrinogen concentration is 
increased, the resulting gels are dense and turbid (composed of thick fibers). If fibrinogen 
concentrations are maintained constant, varying only the concentrations of thrombin, lower 
concentrations lead to the formation of fibrin hydrogels with thick fibers, few branch points 
and large pores, while in opposition, higher concentrations result in a less turbid formation of 
tightly packed thin fibers. Moreover, gel stiffness is also affected by fibrinogen and thrombin 
concentration, mainly by fibrinogen concentration than thrombin’s and normally with greater 
matrix stiffness corresponding to higher concentrations  (Table III). The other variable consists 
in using protease inhibitors to prevent the degradation of fibrin by cell- secreted proteases [70]. 
Protease inhibitors that have been added to fibrin hydrogels in order to slow proteolysis include 
the serine protease inhibitor aprotinin and pharmacological MMP inhibitors [68]. 
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Table III. Effect of fibrinogen and thrombin concentration on fibrin hydrogels mechanical properties.
 
[68]
 
Fibrinogen concentration Thrombin concentration 
 
 Fibrinogen concentration 
 
 
 Fibrin gels dense and turbid, with thick 
fibers; 
 Greater stiffness; 
 
  Fibrinogen concentration 
 
 
 Fibrin gels soft and permissive, with thin 
fibers; 
 Lower stiffness. 
 
  Thrombin concentration 
 
 
Fibrin gels with tightly packed thin fibers and less 
turbid 
 
 
        Thrombin concentration 
 
 
Fibrin gels with thick fibers, few branch points and 
large pores; 
 
 
 
1.4.2. Fibrin as a 3-D matrix for the differentiation of OPCs 
 
 
Fibrin mechanical and biological properties make it an attractive biopolymer to be used as 
a cell carrier. This fibrous, non-globular protein polymerizes in situ without adverse effects 
on co-transplanted cells and with gelation times that allow the use of minimally- invasive 
procedures for the implantation of the cell-loaded matrix. Moreover, fibrin structural and 
mechanical properties can be easily adjusted by varying the concentration of fibrin components 
in fibrin polymerizing solution to prepare suitable environments for OPC culture and neurite 
outgrowth 
[71,72]
. Fibrin gels obtained with low fibrinogen concentrations are more permissive to 
cell infiltration, however these are too soft and thus do not present enough mechanical strength 
and robustness. In this sense, a fibrin scaffold should be both permissive allowing cell infiltration 
and regeneration and hold appropriate mechanical properties to a specific application 
[68]
. 
The advantages of using fibrin as a scaffold include the extremely elastic resistance to 
deformation without breaking and the presence of natural ligands for cell adhesion (two pairs of 
RGD sites and a pair of AGDV sites), proteolytic enzymes (e.g. plasmin), growth factors (e.g. 
FGF-2, FGF-5 and FGF-7, vascular endothelial growth factor (VEGF-B), PDGF-AB, PDGF- BB, PDGF-
DD, TGF-β1, TGF-β2, BMP-2 and BMP-2/7 and neurotrophin-3 (NT-3) and brain- derived 
neurotrophic growth factor (BDNF)) 
[73]
, ECM proteins (e.g. fibronectin), and protease inhibitors 
(including aprotinin, -aminocaproic acid, plasminogen activator inhibitors PAI-1 and PAI-2, α2-
macroglobulin and thrombin activatable fibrinolysis inhibitor) 
[68]
. Recently, Asmani et al. (2013) 
performed the first study reporting fibrin hydrogels as a suitable 3-D support for culture and 
1.4.Fibrin hydrogels as versatile vehicles for cell delivery 
 
19 
differentiation of OPCs derived from endometrial stromal cells, which not only allows cell-cell 
interaction, but also mechanical stimulation similar to that of ECM. In this study, hydrogels with 
three different fibrinogen concentrations (2 mg/mL, 3 mg/mL and 4 mg/mL) were tested. 
Comparing the three gels, it was concluded that the hydrogel with a fibrinogen concentration of 3 
mg/mL provided the best 3-D scaffold to mimic spinal cord environment. The analysis of OPCs 
cell body and the process extensions confirmed the interaction between cells and the fibrin 
scaffold, thereby indicating that OPCs had successfully attached and incorporated into the matrix 
[66]
. 
 
1.4.3. Fibrin functionalization with α6β1 integrin ligands 
 
In opposition to synthetic hydrogels, fibrin is not a passive and non-interactive cell delivery 
matrix, thus allowing specific binding and functionalization with cell delivery domains and 
growth factors in order to enhance their bioactivity and specificity 
[67]
. 
Peptide adhesion domains covalently incorporated within 3-D fibrin matrices can greatly 
increase the bioactivity of the matrix. In addition, the immobilization of these peptides by 
substrates for factor XIIIa seems to provide an effective approach for fibrin gels 
functionalization. Schense et al. (2000) incorporated peptides from laminin and N-cadherin 
either alone or in combination with fibrin hydrogels. In this study, each gel was modified 
with a different bi-domain peptide, containing a factor XIIIa substrate sequence in one domain 
and a different bioactive peptide in the other domain, which included RGD, IKVAV, YIGSR and 
RNIAEIIKDI (derived from the ECM laminin) and HAV (derived from N- cadherin). Neurite 
extension in vitro was enhanced when exogenous peptides were included, with an improvement 
reaching 75%. When tested in vivo, the fibrin derivative containing laminin-derived peptides 
induced an 85% enhancement in the regeneration of the rat dorsal root compared to non-
modified fibrin gels. Therefore, these results demonstrated the possibility to enhance the 
bioactivity of fibrin gels by the enzymatic incorporation of exogenous oligopeptide domais of 
morphoregulatory proteins (e.g. laminin, N-cadherin) 
[74]
. 
As previously referred, growth factors might also enhance the bioactivity of fibrin hydrogels. 
Taylor et al. (2004) developed a heparin-based delivery system (HBDS) to immobilize NT-3 
within fibrin gels, thus allowing the release of NT-3 in a controlled manner, as a therapy for 
SCI. The HBDS system consisted of an immobilized linker peptide which sequesters heparin 
within fibrin gels and then, the sequestered heparin binds NT-3, thereby avoiding its diffusion. 
Fibrin gels containing the HBDS system with NT-3 stimulated neural outgrowth from chick dorsal 
root ganglia up to 54% compared to unmodified fibrin. In a preliminary in vivo study, fibrin gels 
containing the HBDS and NT-3 demonstrated increased neural fiber density in spinal cord lesions 
when compared to unmodified fibrin at 9 days 
[75]
. Sakiyama-Elbert and Hubbell (2000) have 
previously reported the development of an affinity- based drug delivery system designed to slow 
the diffusion of heparin-binding growth factors from fibrin gels. These systems were used to 
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deliver high affinity heparin-binding growth factors such as bFGF 
[76]
, but also low affinity 
neurotrophins, such as nerve growth factor (β- NGF) 
[77]
. 
The tethering of α6β1 ligands (peptides HYD1 and T1) to fibrin was recently explored by our 
lab 
[78]
. 
The angiogenic inducer CCN1 (cysteine-rich 61) is a ligand for several integrins, including 
α6β1. CCN1 interaction with α6β1 was shown to mediate adhesion of fibroblasts, endothelial 
cells and smooth muscle cells, and the T1 sequence within the domain III of CCN1 
(GQKCIVQTTSWSQCSKS) defined as the critical binding motif for α6β1 
[79]
. 
HYD1 (KIKMVISWKG) is a biologically active integrin-targeting synthetic peptide comprised of 
D-amino acids that interacts with α6β1 and α3β1 integrins (non-engaged as well as pre-engaged 
integrin complexes), which, when immobilized, supports the adhesion of tumor cells 
[80]
. When 
added in the soluble form, HYD1 reversibly blocks tumor cell migration on laminin-322, resulting 
into cytoskeletal remodeling, yet stimulating signaling through the activation of FAK and ERK 
[81]
. 
Functionalized hydrogels were obtained binding bi-domain peptides with the α6β1 ligands 
(HYD1 or T1) at the carboxyl terminus and the factor XIIIa substrate domain (NQEQVSPL) at the 
amino terminus to fibrin gels, through the action of factor XIIIa (Figure 7). This strategy is 
reported to be effective for the binding of peptides into fibrin with retention of biological 
activity. Fibrin hydrogels incorporating immobilized HYD1 or T1 synthetic peptides were 
evaluated in terms of ability to promote migration of embryonic stem (ES)-derived neural stem 
progenitor cells (ES-NSPCs) as well as neurite extension from rat sensory neurons . Immobilization 
of T1 and HYD1 efficiently promoted outward migration from ES -NSPC neurospheres. While 
functionalization of fibrin with 20 µM of bidomain HYD1 peptide led to a 2.4-fold increase in 
neurosphere outgrowth area, a 2.2-fold increase was obtained when fibrin was functionalized 
with 40 µM of bidomain T1 peptide. Maximal outgrowth distance on these gels was also found to 
be significantly higher than that observed with unmodified fibrin. Blocking against α6 and β1 
integrin subunits significantly inhibited cell outgrowth from neurospheres on T1/HYD1-
functionalized fibrin gels, indicating that HYD1/T1 ability to promote NSPC migration in fibrin 
gels is partially mediated through α6β1 integrin. Immobilized HYD1 also showed to be efficient 
in promoting neurite extension from rat E18 dorsal root ganglia (DRGs), independently of the 
input peptide concentration tested 
[78]
.  
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Figure 7.Functionalization of fibrin hydrogels with bi-domain peptides (HYD1, T1) with α6β1 ligands at the 
carboxyl terminus and the factor XIIIa substrate domain (NQEQVSPL) at the amino terminus, through the action 
of factor XIIIa. Adapted from: [82] 
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Objective 
 
 
Remyelination of CNS lesions caused by demyelinating disorders such as MS and SCI is still 
a challenging field. Natural remyelination mechanisms are not efficient in advanced stages of 
demyelination, eventually preventing neuronal function recovery. This is mainly due to the 
inhibitory microenvironment that prevents progenitor cells from differentiating into new 
myelinating OLs. In this sense, cell-based therapies have emerged as a promising alternative 
to remyelinate spared axons. The first studies on cell transplantation were performed back in 
the early 80s, demonstrating that transplanted glial cells are capable of remyelinating the 
CNS following their introduction into local injuries. Based on these approaches, many studies 
have been performed since then using different cell types, such as OPCs, Schwann cells, 
olfactory ensheathing cells, NSC lines and ESC-derived glial precursors. All of them had shown 
some progress in remyelinating the CNS lesions. However, cell transplantation by direct 
injection in the form of cell suspensions frequently leads to low cell survival and poor 
proliferation and differentiation. Therefore, combination of cell transplantation with a 
biomaterial-based scaffold can greatly improve the efficacy of the therapies. Although many 
hydrogels have already been used for CNS regeneration therapies, to date, only a few studies 
(Li, et al. (2013); Asmani et al. (2013)) reported the development of hydrogels specifically 
designed for the delivery of OPCs into the CNS. 
 
 
The objective of this Master thesis is  to assess the effect of immobilized α6β1 synthetic 
ligands on OPC behavior in 3D fibrin hydrogels. The functionalization of fibrin with synthetic 
peptides specifically binding to α6β1 integrin is expected to improve fibrin biospecificity 
towards OPCs, namely by promoting cell survival, process extension and myelin membrane 
formation in vitro, and ultimately enhance cell survival of transplanted/recruited OPCs and 
their ability to remyelinate axons in vivo.
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2.1. Cell Culture 
 
2.1.1. Mixed glial cell (MGC) cultures: dissection, plating and culture of neonatal rat 
cortices 
 
Mixed glial cell cultures were obtained by dissecting and isolating the brain cortices of 
P1-P2 (1-2 post natal days) Wistar Han rat pups, and adapted from the the protocols 
developed by McCarthy and deVellis (1980) [83] and Chen (2007) [84]. Pups were sacrificed by 
decapitation with large scissors and the heads were placed in a Petri dish containing cold 
Hank’s Balanced Salt Solution (HBSS) (Gibco, Life Technologies) + 1% penicillin/streptomycin 
10000 U/mL. By holding the nose portion of the head, the skin was cut along the midline 
towards the nose and then, the skull was cut starting at the foramen magnum towards the 
nose and opened, followed by two lateral cuts made until the base of each skull. The two 
sides of the skull were fold back, the brain was scooped out into chilled HBSS supplemented 
with 1% penicillin/streptomycin 10000 U/mL and the cerebellum removed. Each brain was 
divided along into two cerebral hemispheres and exposed. The meninges were removed 
under a Leica S6 E Greenough stereomicroscope to finally isolate the cortex. Meninges-free 
cortices were placed in a clean Petri dish containing HBSS on ice (1 ml per brain). The steps 
are illustrated in Figure 8. 
 
 
Figure 8. Steps of the dissection of the neonatal rat cortex, from the skull cut (a) until the cortex is 
meninges-free and totally isolated (d). Adapted from: [84] 
 
Cortices were then mechanically homogenized by pipetting up and down with a 
serological pipette and a syringe with a 25G needle. Afterwards, the homogenenate was 
enzymatically treated by adding 0,1mg/ml DNAse I (Sigma) and 0,0025% tryps in (Gibco, Life 
Technologies) to HBSS for 15 minutes at 37ºC. Serum-containing medium was added to stop 
trypsinization. Cells were centrifuged (Heraeus Megafuge 1.0) at 500g for 10 minutes, the 
supernatant was discarded and the pellet was resuspended in complete DMEM medium 
(Table IV) and then filtered into a clean 50 mL centrifuge tube through a 100 µm nylon cell 
strainer (BD Falcon). Cells were plated in T75 cm2 poly-D-lysine-coated (Sigma) flasks at a 
density of 2 brains per flask in approximately 12 mL of medium. Cells were incubated in a 
tissue culture incubator with 5% CO2 at 37ºC for approximately 10 days. Medium was changed 
every 2-3 days. 
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2.1.2. OPC isolation and culture 
 
Rat OPCs were obtained from MGC cultures. When MGC cultures are confluent, 
approximately 10 days after plating, astrocytes form a thick layer and microglia and OPCs 
grow on top. Flasks were first pre-shaken on an INFORS AGCH-4103 BOTTMINGEN shaker for 
2 hours at 200 r.p.m. at 37ºC, to remove microglia. The medium was collected and 
discarded, fresh media was added to each flask and the flasks were placed in the incubator 
with 5% CO2 at 37ºC for 1 hour to equilibrate the pH. The flasks were shaked once again, 
this time at 220 r.p.m. overnight at 37ºC to detach OPC. The cell suspension from each flask 
was transferred to an untreated Petri dish (1 Petri dish per flask) and incubated at 37ºC for 
2-3 hours to allow an efficient attachment of contaminant microglia and astrocytes to the 
Petri dish and ultimately isolate OPCs. As OPCs are not adherent in these untreated Petri 
dishes, these were collected from the Petri dishes in the cell suspensions and transferred to 
50 mL centrifuge tube. Cells were centrifuged at 300g for 3 minutes, the supernatant was 
discarded and the pellet was resuspended in approximately 1 mL of OPC SATO 1× (Table IV). 
Live cells were finally observed under optical microscope and counted by Trypan Blue assay. 
 
A summary of dissection, plating and culture of neonatal cortices (A) until OPC isolation 
and culture is displayed (B) in Figure 9. 
 
Figure 9. Summary of dissection, plating and culture of neonatal rat cortices until OPC isolation and 
culture. 
 
Table IV. Summary of media compositions. 
Media nomenclature Base Additional components 
Complete DMEM  DMEM-(1x) Glutamax (Gibco) 10% FBS (F7524, Sigma-
Aldrich) + 1% P/S 
 
 
 
 
 
 
 
 
 
 
100 mg Transferrin (T8158, 
Sigma-Aldrich) 
100 mg BSA (Merck) 
16 mg Putrescine (Sigma-
Aldrich) 
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SATO 10× 
(150 mL) 
 
 
DMEM-(1×) Glutamax (Gibco) 
(up to 150 mL) 
 
60 µL Progesterone (1 mg/mL 
ethanol) (Sigma-Aldrich) 
40 µL Na Selenite (1 mg/mL 
0.1 NaOH) (Sigma-Aldrich) 
40 µL Thyroxine (1mg/mL 0.1 
NaOH) (Sigma-Aldrich) 
30 µL Triiodo L-thyronine 
(1mg/mL 0.1 NaOH) (Sigma-
Aldrich) 
 
 
OPC SATO 1× 
(Proliferation medium) 
 
 
DMEM-(1×) Glutamax (Gibco) 
+ SATO 10× 
10% P/S (10 mg/mL), 
Human insu lin  (final 
c onc entration  5 µg/mL) + 
human PDGFα(AA) (final 
c onc entration  10 ng/mL) 
+ human FGF (basic ) (final 
c onc entration  10 ng/mL) 
 
 
OL SATO 1× 
(Differentiation medium) 
 
DMEM-(1×) Glutamax (Gibco) 
+ SATO 10× 
10%Penic illin  
Streptomyc in  (10 
mg/mL), Human insu lin  
(final c onc entration  5 
µg/mL) + FBS  
 
 
2.2. OPC culture in fibrin hydrogels 
 
2.2.1. Preparation of fibrin hydrogels 
 
Prior to be used in the preparation of fibrin gels, fibrinogen was dissolved in ultra-pure 
water, dialysed against tris-buffered saline (TBS, pH 7.4), sterile-filtered, and diluted to 12 
mg/mL with sterile TBS. 
Polymerizing fibrin hydrogels, formed by applying equal volumes of a solution of 
plasminogen-free fibrinogen from pooled human plasma and a thrombin solution(all Sigma), 
containing CaCl2 (Merck) and the bi-domain peptides HYD1, T1 or HYD1+T1 (GenScript), into the 
lower wells of a µ-Slide 8 Well ibiTreat(Ibidi®) (final concentration of fibrin components: 2, 4, 
6, or 8 mg/mL fibrinogen; 2 NIH U/mL thrombin from human plasma; 2.5 mM CaCl2; 5, 10 or 20 
µM of the bi-domain peptides) (Figure 10). 
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Figure 10. One-drop system for preparing 30µL Fibrin drops.  
1 and 2. Take 15µL of the fibrinogen solution and place it on the lateral side of the Eppendorf; take 
15µL of the thrombin working solution and add it to the fibrinogen drop; 
3 Carefully transfer the 30 µL of fibrin polimerizing solution to a well of the µ-slide 8 Well ibiTreat; 
4 Allow to polymerize for 30 minutes at 37ºC; 
5 Add OPC SATO 1× supplemented with 5 µg/mL Aprotinin. 
 
After being centrifuged at 200g for 3 minutes at 4ºC (eppendorf centrifuge 5417R) OPCs 
were resuspended in the correspondent fibrinogen solution prior polymerization. Further 
incubation at 37ºC with CO2 for 30 min ensured full polymerization due to fibrinogen 
crosslinking by factor XIIIa (present in fibrinogen solution). 
At the end of the polymerization period, 300 µL of OPC SATO 1× supplemented with 5 
µg/mL Aprotinin from bovine lung (Sigma) were added to each well of the µ-Slide 8 well 
After 2 days under proliferation conditions, the proliferation medium was switched to a 
differentiation medium, OL SATO 1×. The differentiation medium supplemented with 
aprotinin was changed every 2 days until the end of the culture period. 
 
2.2.1.1.Preparation of unmodified fibrin hydrogels 
To evaluate the effect of the fibrinogen concentration on OPC behavior, fibrin gels with 
fibrinogen concentrations ranging from 2 – 8 mg/mL were prepared by poly  
OPCs were embedded in fibrin hydrogels and cultured for 9 days, 2 days under proliferation 
conditions and 5 days under differentiation conditions.  
At the end of the culture period, the effect of fibrinogen concentration on cell viability 
and process extension were assessed.  
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2.2.1.2.  Preparation of fibrin hydrogels functionalized with T1, HYD1 and HYD1+T1 
 
Fibrin gels were functionalized with HYD1 peptide, T1 peptide (GenScript) and a 
combination of both HYD1 and T1 peptides. Peptides were covalently bound to fibrin using 
the enzymatic cross-linking action of transglutaminase factor XIIIa. Fibrin gels with peptide 
concentrations of 5 µM, 10 µM and 20 µM were prepared. 
OPCs were embedded in fibrin hydrogels functionalized with α6β1 ligands and cultured for 
5 days, 2 days under proliferation conditions and 3 days under differentiation conditions. 
At the end of incubation period the effect of bi-domain peptides concentration on OPC 
process extension and myelin membrane formation was assessed. 
  
2.3. Immunocytochemistry 
 
2.3.1. F-actin/DNA fluorescent staining  
 
Cells were fixed with 2% paraformaldehyde (Merck) in culture medium for 30 minutes 
in the incubator, washed and stored in PBS at 4ºC, until being immunostained. Cells were 
permeabilized with 0.2% (v/v) Triton X-100 (T-8787; Sigma) in PBS (P-3813; Sigma) for 45 
minutes and washed with PBS. To minimize non-specific staining, the samples were 
incubated with 1% (w/v) Bovine Serum Albumin (BSA) solution (Merck) in PBS for 2-3 hours 
as a blocking solution, followed by the incubation with Alexa Fluor 594 phalloidin 
(Molecular Probes) diluted 1:40 in the 1% BSA solution overnight at 4ºC, in the dark and 
under stirring (50 r.p.m.). After washing with PBS, the samples were incubated with 0.1 
µg/mL 4’,6-Diamidino-2-phenylindole dihydrochloride (DAPI) (Sigma). Finally, the samples 
were washed with PBS then again and kept in Fluor FluoromountTM Aqueous Mounting 
Medium (Sigma) at 4ºC in the dark until analysis in the high throughput fluorescence 
microscope InCell Analyzer 2000 (GE Healthcare).. Alexa Fluor® 594 phalloidin is a toxin 
with high-affinity for F-actin conjugated with red fluorescent Alexa Fluor® 594 dye 
(Excitation/Emission: 581/609 nm). 
 
2.3.2. Immunostaining of α-tubulin and oligodendrocyte specific nuclear marker 
Olig2 
 
Cells were fixed with 2% paraformaldehyde (Merck) in culture medium for 30 minutes 
in the incubator, washed and stored in PBS at 4ºC, until being immunostained. 
Cells were permeabilized with 0.1% (v/v) Triton X-100 in PBS for 45 minutes and washed 
with PBS. The samples were incubated with a blocking buffer of 5% Normal Goat Serum 
(NGS) (Sigma) and 3% Donkey Serum (DS) (Sigma) in PBS for 2-3 hours to minimize non-
specific staining of the antibodies prior to the incubation with the primary antibodies: 
mouse monoclonal anti-α-tubulin antibody (Sigma-Aldrich) diluted 1:2000 and rabbit anti-
Olig2 polyclonal antibody (Merck-Millipore) diluted 1:500 in PBS containing 5% NGS and 3% 
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DS, overnight at 4ºC, in the dark and under stirring (50 r.p.m.). After washing with PBS 
containing 5% NGS and 3% DS, the samples were incubated with the secondary antibodies: 
Alexa Fluor® 488 conjugate F(ab')2-Goat anti-Mouse IgG (H+L) Secondary Antibody, 
(Invitrogen) and Alexa Fluor® 647 conjugate Donkey anti-Rabbit IgG (H+L) Secondary 
Antibody (Invitrogen), both diluted 1:1000 in PBS containing 5% NGS and 3%DS for 6 hours 
at 4ºC. After washing with PBS, nuclei were stained with DAPI diluted 1:10000 in PBS. The 
samples were washed with PBS and finally kept in FluoromountTM Aqueous Mounting 
Medium at 4ºC in the dark until CLSM observation.  
 
2.3.3. Immunostaining of α-tubulin and oligodendrocyte specific Myelin Basic 
Protein (MBP) 
 
Cells were fixed with 2% paraformaldehyde (Merck) in culture medium for 30 minutes in 
the incubator, washed and stored in PBS at 4ºC, until being immunostained. 
Cells were permeabilized with 0.1% (v/v) Triton X-100 in PBS for 45 minutes and washed 
with PBS. The samples were incubated with a blocking buffer of 5% NGS in PBS for 2-3 hours 
to minimize non-specific staining of the antibodies prior to the incubation with the primary 
antibodies: mouse monoclonal anti-α-tubulin antibody (Sigma-Aldrich) diluted 1:2000 and 
MBP chicken polyclonal anti-peptide antibody mixture (100 μg/mL) (MBP, Aves Labs Inc.) 
diluted 1:500 in PBS containing 5% NGS, overnight at 4ºC under s tirring (50 r.p.m.). After 
washing with PBS containing 5% NGS, the samples were incubated with the secondary 
antibodies: Alexa Fluor® 594 conjugate Goat anti-Mouse IgG (H+L) Secondary Antibody, 
(Invitrogen) and Alexa Fluor® 488 conjugate Goat anti-Chicken IgY (H+L) Secondary 
Antibody, both diluted 1:1000 in PBS containing 5% NGS for 6 hours at 4ºC. After washing 
with PBS, nuclei were stained with DAPI diluted 1:10000 in PBS (final concentration: 0.1 
µg/mL). The samples were washed with PBS and finally kept in FluoromountTM Aqueous 
Mounting Medium at 4ºC in the dark until CLSM observation.  
 
2.3.4. Cell viability assay 
 
OPCs viability in 3D fibrin gels was assessed by incubating cells with Calcein AM and 
Propidium Iodide (PI) (Sigma) after 9 days of culture (2 days under proliferation and 7 days 
under differentiation. Hoechst 33342 Fluorescent Stain was used to stain DNA. Calcein AM 
freely diffuses into the cells, and is hydrolyzed by nonspecific esterases into fluorescent 
products that are retained by cells with intact plasma membranes. Propidium iodide (PI) is 
used as counterstain to identify nonviable cells. PI readily enters and stains cells with 
compromised membranes but cannot cross the membranes of viable cells.  
A 2.8 µg/mL Hoechst 33342 (Molecular Probes) solution in PBS was initially prepared. 
Briefly, the cell/fibrin constructs were incubated with 2 µM of Calcein AM (Invitrogen 
Molecular Probes) diluted in the Hoechst 33342 solution, for 20 minutes at 37ºC in the dark. 
After removing this solution, cells were incubated with 2 µM of PI diluted in PBS for 10 
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minutes at 37ºC in the dark. Finally, pre-warmed OL SATO 1× supplemented with 5 µg/mL 
aprotinin was added and the samples were observed under CLSM as soon as possible (Calcein 
AM excitation/emission: 488/530 nm; PI excitation/emission: 535/617 nm).
 
2.3.5.  Apoptosis assay 
 
OPCs apoptosis and cell death was assessed using Annexin V-FITC Apoptosis Detection 
Kit (Biotool) after 9 days of culture. This kit uses recombinant annexin V conjugated to 
green-fluorescent fluorescein isothiocyante (FITC) dye to detect the externalization of 
phosphatidylserine in apoptotic cells and PI to detect necrotic cells by fluorescence 
microscopy. After incubation with these probes, apoptotic cells show green fluorescence 
and dead cells show red and green fluorescence, while live cells show little or none.  
Cells were incubated with Annexin V-FITC and PI Staining solution both diluted 1:20 in 
1x Binding Buffer for 20 minutes at room temperature. After the incubation period, cells 
were first washed with cold PBS and then kept in 1x Binding Buffer on ice until CLSM 
observation, which was performed as soon as possible. 
 
2.4. Process outgrowth quantification 
 
To assess if both fibrinogen concentration in the gels and functionalization with bi -
domain peptides had significant effects in process outgrowth, IN Cell Developer Toolbox 
software was used for the acquisition of 3D images of the fibrin gels. 
IN Cell Analyzer 2000 (GE Healthcare) is a widefield automated high throughput 
microscope. These systems are designed to provide the user with the throughput and 
performance necessary for both high content analysis and screening. 
Since the purpose was to observe the OPC process extension in a 3D environment, the 
bottom of the gel, more specifically the interface where the gel meets the plastic surface 
of the well, was avoided in the acquisition whenever possible. The top and the bottom of 
the gels were found by performing sequential focus planes up and down in the DAPI channel 
until nuclei stopped being seen clearly. The mean between the top and the bottom of the 
gel was calculated. By considering an offset=0, a z position is obtained, which is subtracted 
to the mean. The value obtained is the offset to be considered in the acquisition. For each 
condition tested, 21 z-stacks of 64-72 fields were acquired, using a magnification of 20×0.75 
Pan Apo.  
The number of processes in OPCs was quantified using the Freehand Line function of 
ImageJ software, as shown in Figure 11. Only Olig2+ cells were considered for the 
quantification. 
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Figure 11. Manual OPC process counting and measurement using Freehand Line (in yellow) and 
Measure function from ImageJ software. 
 
 
2.5. Apoptotic and dead cell quantification 
 
To quantify the results correspondent to cell viability and apoptosis, the function Spot 
Detector from Icy Bio-Imaging Software was used. The Spot detector allows the user to count 
cells by detecting spots in noisy 3D images by defining parameters such as the input 
sequence, the type of detector, the scale and the type of filtering. A batch of files 
corresponding to CLSM z-stacks of the Hoechst 33342 channel, the PI channel or Annexin 
channel were loaded into the program as input sequences. After selecting the scale and the 
size of spots to be detected, the computation starts, displaying an image with the detection 
markers and a binary image for control as output. The output data is directly exported to 
Excel. With these data, the percentage of dead cells and apoptotic cells could be calculated. 
Cell viability (%) for each concentration was calculated by image analysis of the 2-D PI/DNA 
projected stacks, counting the total cell number (Hoechst 33342) and dead cells (PI) using 
the spot detector function from Icy Software and subtracting the obtained percentages to 
100% to obtain the percentage of viable cells. A similar principle was used to calculate the 
percentage of apoptotic cells, using 2-D Annexin V/DNA projected stacks. 
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2.6. Statistical Analysis 
 
Fibrin gels prepared with different fibrinogen concentrations were compared using one-way 
ANOVA followed by the Bonferroni post-hoc test for multiple comparisons (whenever 
homogeneity of variances was observed) or the Kruskal-Wallis non-parametric test (in case 
of homogeneity of variances was not observed) followed by the the Mann-Whitney U test 
for two sample comparisons. 
Statistically significant differences between functionalized fibrin gels and unmodified gels  
(control) were assessed using the unpaired t-test. Functionalized fibrin gels were compared 
among them using one-way ANOVA.   
Statistical treatment of data was performed using IBM® SPSS® Statistics Software (version 
20). Results were considered significant for p < 0.05. 
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3.1. Optimization of OPC 3-D culture in fibrin hydrogels  
 
For optimization of OPC 3-D cell culture in fibrin hydrogels, different cell seeding densities and 
aprotinin concentrations were initially investigated. 
 
For this purpose, OPCs were seeded in fibrin hydrogels (prepared with fibrinogen concentrations 
ranging from 2 to 8 mg/mL) at 0.5, 0.75, 1.0, and 1.25 × 106 cells/mL of fibrin hydrogel and cultured 
for 7 days in the presence (1 or 5 µg/mL) or absence of aprotinin, a cell protease inhibitor. At the 
end of the culture period, the cell/fibrin constructs were processed for F-actin/DAPI staining, to 
qualitatively assess cell distribution and process extension within fibrin hydrogels. Results 
correspondent to OPCs entrapped in fibrin hydrogels prepared with 4 mg/mL of fibrinogen and 
cultured in the presence of 5 µg/mL of aprotinin are presented in Figure 12.  
 
 
Figure 12. Distribution of OPCs within 3-D fibrin gels after 7 days of cell culture, as a function of the cell 
seeding density: (A) 0.5 × 106 cells/mL; (B) 0.75 × 106 cells/mL; (C) 1 × 106 cells/mL; (D) 1.25 × 106 cells/mL. 
Cell/fibrin constructs were cultured for 7 days, 2 days under proliferation conditions and 5 days under 
differentiation conditions in the presence of aprotinin (5 µg /mL), and subsequently processed for fluorescent 
labelling of and F-actin (in green) and DNA (in blue). Representative 2-D projections of stitched InCell Analyzer 
images of cell/fibrin constructs prepared with 4 mg/mL of fibrinogen and covering a depth of 
approximately~100 µm, are presented. Scale Bar: 200 µm. 
A C
0.5 M 
A A 
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 Results revealed a trend for the presence of cell clusters with radially-migrating OPCs and fibrin 
degradation halos (the latter better observed under phase contrast microscopy) with increasing cell 
seeding densities (Fig. 12). Although the initial OPC suspension was mainly constituted by single 
cells, cell clusters could also be detected, suggesting that the observed cell clusters result of 
incomplete cell dissociation during the OPC isolation procedure. Increasing cell seeding densities 
led to the presence of more cell clusters. Since fibrin hydrogels seeded with 0.75 × 106 cells/mL 
presented a homogeneous distribution of cells and very few cell clusters as compared to hydrogels 
seeded with higher cell numbers, (Fig. 12B), this cell seeding density was selected for all subsequent 
assays. Aprotinin has shown to be required to avoid overall fibrin degradation. In its absence, fibrin 
hydrogels completely degraded overtime, independently from the initial cell seeding density and 
fibrinogen concentration tested. A 5 µg/mL aprotinin concentration was found to be sufficient to 
delay fibrin degradation while allowing fibrin degradation by migrating cells and process extension 
better observed at higher magnifications).
 
3.2. Effect of fibrinogen concentration on OPC behavior 
 
Although for certain clinical applications such as in hemostatic plugs, fibrin hydrogels with high 
fibrinogen concentrations are desirable (due to their shorter gelation time at physiological 
conditions and higher resistance to enzymatic degradation), for use as a matrix for cell ingrowth 
and tissue engineering, fibrin gels with viscoelastic properties matching those of the native tissue 
are required, due to cell mechanosensing. Fibrin gels too stiff may hinder OPC survival, proliferation 
and differentiation. As among fibrin components, fibrinogen concentration is the one affecting fibrin 
structural and viscoelastic properties at a greater degree [68], the fibrinogen concentration leading 
to better retention of OPC viability and differentiation was first established. The selected 
concentration was be used for the functionalization studies. 
 
 
3.2.1.  Effect of fibrinogen concentration on OPC process 
outgrowth 
 
OPC differentiation into myelinating OLs in a 3-D environment was evaluated by analyzing the 
process extension. To assess the effect of fibrinogen concentration on OPC process outgrowth in 
fibrin gels, OPCs were embedded in fibrin hydrogels prepared with increasing fibrinogen 
concentrations (2, 4, 6, and 8 mg/mL), and cultured for 9 days, 2 days with proliferation medium 
(OPC SATO 1×) and 7 days in differentiation medium (OL SATO 1×). At the end of this period, process 
extension was evaluated in cell/fibrin constructs previously processed for immunofluorescent 
labelling of α-tubulin and Olig2. An oligodendrocyte-specific nuclear marker (Olig2, a transcription 
factor promoting the formation of OPCs and their differentiation into OLs at later stages of 
development) was used to identify OLs, as primary cultures of OPCs might also contain astrocytes 
1 M 
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and microglial cells as contaminants. Representative 2-D projections of CLSM stack images of 
cell/fibrin constructs are presented in Figure 13. Cellular processes containing α-tubulin (in green) 
were observed in all fibrin hydrogels, independently of the fibrinogen concentration, indicating that 
all hydrogels were permissive to OPC process extension. Still, for the lowest fibrinogen concentration 
tested (2 mg/mL), only a thin layer of fibrin matrix remained at the end of the cell culture period, 
regardless of medium supplementation with 5 µg/mL of aprotinin. This observation suggests that 
fibrin hydrogels prepared with 2 mg/mL of fibrinogen are not suitable for the 3-D culture of OPCs 
when considering a cell seeding density of 0.75 × 106 cells/mL, due to its fast degradation by cell-
secreted proteases. Among the fibrin hydrogels tested, those correspondent to 4 and 6 mg/mL of 
fibrinogen revealed more frequently Olig2+ cells extending processes, while those of 8 mg/mL 
revealed mostly cells with round morphology and extending few processes, as well as a tendency for 
cell aggregation. 
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Figure 13. Immunocytochemistry analysis of OPC process extension in fibrin hydrogels as a function of 
fibrinogen concentration. Cell/fibrin constructs were cultured for 9 days (2 days under proliferation conditions 
and 7 days under differentiation conditions) and subsequently processed for immunofluorescent labelling of α-
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tubulin/olig2. Representative 2-D projections of CLSM stack images of cell/fibrin constructs covering a depth 
of approximately 30 µm are presented. Scale Bar: 100 µm.  
 
Following the qualitative analysis of 2-D CLSM projections suggesting that fibrin gels prepared with 
4 mg/mL and 6 mg/mL of fibrinogen were more permissive to OPC process extension, quantitative 
image analysis was performed. Three parameters were evaluated to quantify process outgrowth: 
process number, maximum length and average length. The results obtained are presented in Figure 
14. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Quantitative analysis of process outgrowth of OPCs cultured in fibrin hydrogels, as a function of 
fibrinogen concentration. Cell/fibrin constructs were cultured for 9 days, 2 days under proliferation conditions 
and 7 days under differentiation conditions, and subsequently processed for immunofluorescent labelling of α-
tubulin and olig2. Process outgrowth was determined in InCell Analyzer stack images of cell/fibrin constructs 
covering a depth of approximately~200 µm, by image analysis. Only cells expressing olig2 were considered for 
the analysis. To evaluate process extension three parameters were considered: (A) Mean process number; (B) 
Mean maximum length; (C) Mean average length. In each experiment, 45-60 cells were analyzed in two replicate 
cultures. Mean values from three independent experiments are shown (*, p < 0.05; **, p < 0.01; ***, p < 0.005, 
as determined using the one-way ANOVA test followed by Bonferroni post-hoc test for multiple comparisons). 
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Fibrin hydrogels prepared with the lowest fibrinogen concentration tested (2 mg/mL) revealed 
a trend to have cells with lower number of processes per cell as well as with lower values of 
maximum length and average length, when compared to fibrin hydrogels prepared with 4 mg/mL of 
fibrinogen. The higher degradation rate observed in these gels may partially explain these 
differences, since cells presenting well developed processes had to be excluded from the analysis 
for being too close from the bottom of the wells.  
Among the fibrin hydrogels tested, those prepared with 4 mg/mL and 6 mg/mL of fibrinogen 
showed the highest mean of number of processes (7.0 ± 0.3 and 6.3 ± 0.7, respectively; Fig. 14A), 
in line with the qualitative CLSM analysis of OPC sprouting in fibrin (Fig. 13). Although fibrin gels 
prepared with 4 mg/mL of fibrinogen presented a higher mean of number of cellular processes as 
compared to gels with 6 mg/mL of fibrinogen, this difference was not found to be statistically 
significant. Also when considering the mean of the maximum length and of the average length, 
higher values were found for fibrin gels prepared with 4 mg/mL of fibrinogen than for gels with 6 
mg/mL of fibrinogen, although no significant differences were found (Fig. 14B and C). Increasing 
the fibrinogen concentration to 8 mg/mL led to a decrease of the mean of the number of processes 
(3.9 ± 0.5), a decrease which was found to be statistically significant when compared to fibrin gels 
with 4 or 6 mg/mL of fibrinogen. Nevertheless, the increase of fibrinogen concentration to 8 mg/mL 
did not significantly impact the mean of the maximum length or of the average process length (Fig. 
14B and C). 
 
Apart from comparing the mean values of the different process outgrowth parameters from each 
independent experiment, process outgrowth values pooled from the three independent experiments 
were also compared. Results are presented in Figure A1 (Appendix A). In line with the previous 
analysis, increasing the fibrinogen concentration to 8 mg/mL resulted in a s ignificant decrease of 
the number of cellular processes when comparing to fibrin gels with 4 or 6 mg/mL of fibrinogen (Fig. 
A1.A). Also in accordance with the previous analysis, the increase in fibrinogen concentration to 8 
mg/mL did not significantly influence the two other process outgrowth parameters evaluated 
(maximum process length and average process length) (Fig.A1.B and A1.C).  
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3.2.2. Effect of fibrinogen concentration on OPC viability  
 
Cell viability of OPCs embedded in fibrin hydrogels prepared with increasing fibrinogen 
concentrations (2, 4, 6, and 8 mg/mL) was assessed at the end of 9 days of cell culture (2 days under 
proliferation and 7 days under differentiation conditions), incubating the cell/fibrin constructs with 
Calcein AM/PI, and Hoescht 33342. Representative 2-D projections of CLSM stack images are shown 
in Figure 15A. 
 
 
 
 
 
 
 
 
 
 
Figure 15. Cell viability of OPCs cultured in fibrin hydrogels, as a function of fibrinogen concentration. 
Cell/fibrin constructs were cultured for 9 days, 2 days under proliferation conditions and 7 days under 
differentiation conditions, and subsequently incubated with Calcein AM, PI and Hoescht 33342, for detection 
of live (in green), dead (in red), and DNA (in blue), respectively. (A) Representative 2-D projections of CLSM 
stack images of cell/fibrin constructs covering a depth of approximately 100 µm. Scale Bar: 200 µm. (B) 
Percentage of viable cells, as determined by image analysis of the 2-D projected CLSM stacks. Results from 
three independent experiments are shown (mean ± standard deviation). Results were not considered 
statistically significant (One-way ANOVA test). 
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The percentage of viable cells was estimate by image analysis, subtracting the number of PI+ 
cells to the total cell number. Image analysis of CLSM stack images revealed for fibrin gels prepared 
with 4 mg/mL of fibrinogen the highest percentage of viable cells (74 ± 7 %) while the lowest (60 ± 
7 %) was observed for gels prepared with 8 mg/mL of fibrinogen, the highest fibrinogen 
concentration tested. Still, the fibrinogen concentration was not found to alter significantly OPC 
viability, within the range of fibrinogen concentration tested.
 
As OPCs cultured in 3-D fibrin gels prepared with 4 mg/mL of fibrinogen revealed better overall 
in vitro biological performance, this fibrinogen concentration was used in the functionalization 
studies.
 
3.3. Effect of immobilized α6β1 ligands on OPC behavior in 3-D fibrin 
hydrogels 
 
Fibrin gels were functionalized with bi-domain peptides known to interact specifically with α6β1 
integrin and the effect of immobilized α6β1 ligands on OPC process outgrowth, myelin membrane 
formation, and apoptosis, evaluated. 
 
3.3.1.  Effect of immobilized α6β1 ligands on OPC process 
outgrowth 
 
To assess the effect of immobilized α6β1 ligands on OPC process outgrowth, OPCs were 
embedded in fibrin hydrogels (4 mg/mL of fibrinogen) functionalized with increasing molar 
concentrations (5, 10 and 20 µM) of bi-domain peptides (HYD1, T1, and the combination of HYD1 
with T1), and cultured for 5 days (2 days under proliferation conditions and 3 days under 
differentiation conditions). Process outgrowth was evaluated at day 5 of cell culture (instead of day 
9 of cell culture), to avoid overlapping of cell processes extending between neighboring cells, which 
could compromise image analysis of OPC projections. 
OPC process outgrowth was evaluated in cell-fibrin constructs previously processed for 
immunofluorescent labelling of α-tubulin and Olig2. Representative 2-D projections of CLSM stack 
images of cell/constructs are presented in Figure 16. OPC process extension in fibrin hydrogels was 
not hindered by functionalization with bi-domain peptides, independently of the immobilized 
peptide and of the peptide concentration, since Olig2+ cells with cellular processes containing α-
tubulin (in green) were observed in all functionalized hydrogels.  
The quantitative analysis of process outgrowth (mean process number per cell, mean maximum 
length and mean average length) is presented in Figure 17. Functionalization of fibrin with HYD1 
bi-domain peptide resulted in a 1.4-fold increase in the mean number of cellular processes (p  
0.05), already for the lowest peptide input concentration tested (5 µM; Fig. 17.A). Still, increasing 
the concentration of bi-domain peptide from 5 µM to 10 or 20 µM did not result in a significant 
increase of the mean number of cellular processes, as assessed by one-way ANOVA. Immobilization 
of HYD1 also resulted in an increase in the mean of maximum length, although statistically significant 
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differences were not observed. Similarly, when considering the mean of the average length, no 
statistically significant differences were found between HYD1-functionalized fibrin hydrogels and 
unmodified gels, regardless of the input HYD1 bi-domain peptide concentration. 
 
Functionalization of fibrin with T1 bi-domain peptide also revealed to be effective in increasing the 
mean number of cellular processes (1.3-fold increase, p  0.005) and to higher values of maximum 
process length (1.2-fold increase), already for the lowest peptide input concentration tested (5 µM; 
Fig. 17.B), even though the differences in the mean of maximum length were not considered 
statistically different. Increasing the concentration of bi-domain peptide from 5 µM to 10 or 20 µM 
did not result in a significant increase either of the number of cellular processes or of the maximum 
process length. Following the trend observed for HYD1-functionalized gels, no statistically significant 
differences were found between T1-functionalized fibrin hydrogels and unmodified gels in terms of 
average process length, independently of the input T1 bi-domain peptide concentration. 
 
Functionalization with both the bi-domain peptides (HYD1 and T1) led to an increase in the 
number of cellular processes (1.4-fold increase, p  0.05) for the lowest input concentration tested 
(5 µM; Fig. 17.C). The functionalization with a combination of both peptides also led to higher values 
of maximum process length (1.13-fold increase) although the differences were not considered 
statistically different. Still, when considering this input concentration, no additive/synergetic effect 
of the two bi-domain peptides was found, since the values of the mean of the process number and 
of the maximum process length found in fibrin gels functionalized with a single bi-domain peptide 
do not differ significantly from those found in gels functionalized with both the bi-domain peptides 
(Fig.18). Once more, increasing the concentration of bi-domain peptides from 5 µM to 10 or 20 µM 
did not result in a significant increase either of the number of cellular processes or of the maximum 
process length (Fig. 17.C). Finally, no statistically significant differences were found between 
(HYD1+T1)-functionalized fibrin hydrogels and unmodified gels in terms of average process length, 
independently of the input bi-domain peptides concentration. 
 
Apart from comparing the mean values of the different process outgrowth parameters from 
each independent experiment, process outgrowth values pooled from the three independent 
experiments were also compared. Results are presented in Figure F1 (Appendix F). In line with 
the previous analysis, the functionalization with HYD1, T1 or the combination of both bi-domain 
peptides was successful in promoting an increase in the number of cellular processes, for the lowest 
peptide concentration 5 µM (Fig. F1.A). Also in accordance with the previous analysis, no 
additive/synergetic effect of combining the two bi-domain peptides was found (Supplementary 
Data – Figure F2). 
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Figure 16. Immunocytochemistry analysis of OPC process extension in 4 mg/mL fibrin hydrogels functionalized 
with bi-domain peptides (HYD1, T1 and HYD1+T1), as a function of peptide input concentration in polymerizing 
gels. Cell/fibrin constructs were cultured for 5 days (2 days under proliferation conditions and 3 days under 
differentiation conditions) and subsequently processed for immunofluorescent labelling of α-tubulin (in 
green)/olig2 (in red). Representative 2-D projections of CLSM stack images of cell/fibrin constructs covering a 
depth of approximately 30 µm are presented. Red arrows indicate Olig2+ cells. 2-D projections of split CLSM 
stack images are presented in Supplementary Data – Appendix C, D and E. Scale Bar: 50 µm. 
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Figure 17. Process outgrowth quantitative analysis of OPCs cultured in fibrin hydrogels (4 mg/mL of fibrinogen) 
functionalized with bi-domain peptides, as a function of peptide input concentration in polymerizing gels: (A) 
HYD1; (B) T1 and (C) HYD1+T1. Cell/fibrin constructs were cultured for 5 days (2 days under proliferation 
conditions and 3 days under differentiation conditions), as assessed by image analysis of InCell Analyzer z-stacks 
covering a depth of approximately 200 µm. To evaluate process extension three parameters were considered: 
(A) Mean process number; (B) Mean maximum length; (C) Mean average length. In each experiment, 45-60 cells 
were analyzed in two replicate cultures. Mean values from three independent experiments are shown. Process 
outgrowth in functionalized fibrin hydrogels was compared to that in unmodified gels  (*, p < 0.05; **, p < 0.01; 
***, p < 0.005). Functionalized gels were compared among them and no statistically significant differences were 
found (as assessed by one-way ANOVA). 
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Figure 18. Process outgrowth quantification of OPCs cultured in 4 mg/mL fibrin hydrogels functionalized with 
5 µM of bi-domain peptides (HYD1, T1 and HYD1+T1). Cell/fibrin constructs were cultured for 5 days (2 days 
under proliferation conditions and 3 days under differentiation conditions), as assessed by image analysis of 
InCell Analyzer z-stacks covering a depth of approximately 200 µm. Three parameters were considered to 
evaluate process extension: (A) Mean process number; (B) Mean maximum length; (C) Mean average Length. In 
each experiment, 45-60 cells were analyzed in two replicate cultures. Mean values from three independent 
experiments are shown. Results were not considered statistically different as assessed by one-way ANOVA. 
 
3.3.2.  Effect of immobilized α6β1 ligands on myelin membrane 
formation 
 
To assess the effect of immobilized α6β1 ligands on OL myelin production, OPCs were embedded 
in fibrin hydrogels (4 mg/mL of fibrinogen) functionalized with increasing molar concentrations (5, 
10 and 20 µM) of bi-domain peptides (HYD1, T1, and the combination of HYD1 with T1), and cultured 
for 5 days (2 days under proliferation conditions and 3 days under differentiation conditions). Myelin 
deposition was evaluated at day 5 of cell culture in cell/fibrin constructs previously processed for 
immunofluorescent labelling of α-tubulin and myelin basic protein (MBP), an important 
differentiation marker exclusively expressed by myelinating OLs in the CNS, localized on the 
cytoplasmic surface of the plasma membrane and myelin membrane. Representative 2-D projections 
of CLSM stack images of cell/fibrin constructs are presented in Figure 19. 
Myelin membrane formation in fibrin hydrogels was not hindered by functionalization with bi-
domain peptides, independently of the immobilized peptide and of the peptide concentration, since 
cells expressing MBP (in green) were observed in all functionalized hydrogels. This can be better 
observed in 2-D projections of split MBP channel (green) stack images presented in Supplementary 
data – Appendix G. 
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Figure 19. Immunocytochemistry analysis of OL myelin production in 4 mg/mL fibrin hydrogels functionalized 
with bi-domain peptides (HYD1, T1 and HYD1+T1), as a function of peptide input concentration in polymerizing 
gels. Cell/fibrin constructs were cultured for 5 days, 2 days under proliferation and 3 days under differentiation 
3.3. Effect of immobilized α6β1 ligands on OPC behavior in 3-D fibrin hydrogels 
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conditions, and subsequently processed for immunofluorescent labelling of α-tubulin (in green) and anti-MBP 
(in red). Nuclei are shown in blue. Representative 2-D projections of CLSM stack images of cell/fibrin constructs 
covering a depth of approximately 30 µm are shown. 2-D projections of split MBP channel (green) stack images 
are presented in Supplementary Data – Appendix G. Scale Bar: 50 µm. 
 
3.3.3. Effect of immobilized α6β1 ligands on OPC apoptosis 
 
An apoptosis assay was performed to address if functionalization of fibrin hydrogels with α6β1 
ligands could compromise OPC viability. In this assay, early apoptotic cells were stained with annexin 
V and dead cells with PI. Apoptosis was evaluated in OPCs cultured in fibrin hydrogels (4 mg/mL of 
fibrinogen) functionalized with 5 µM of bi-domain peptides (HYD1, T1 and the combination of HYD1 
with T1), at the end of 9 days of cell culture (2 days under proliferation conditions and 7 days under 
differentiation conditions). Representative 2-D projections of CLSM stack images of cell/fibrin 
constructs incubated with annexin V and PI are shown in Figure 20A. Image analysis revealed for 
unmodified fibrin 46% of early apoptotic cells, and for functionalized fibrin hydrogels, percentages 
of apoptotic cells ranging from 30 to 47 %. Among functionalized fibrin hydrogels, those 
functionalized with HYD1 showed the lowest percentage of apoptotic cells (30%). The percentage of 
PI+ cells in unmodified fibrin was 15%, and among functionalized hydrogels, those functionalized 
with HYD1 revealed the lowest percentage of dead cells (4%). Still, in gels functionalized with both 
HYD1 and T1, 38% of dead cells were found. Nevertheless, it should be noted that these results 
correspond to a single experiment and no obvious conclusions can be obtained from this data, as 
statistical analysis could not be performed.  
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Figure 20. (A) Apoptotic analysis of OPCs cultured in unmodified 3-D fibrin hydrogels (4 mg/mL of fibrinogen) 
or fibrin hydrogel functionalized with 5 µM of HYD1, T1 and HYD1+T1. OPCs were cultured for 9 days (2 days 
under proliferation and 7 days under differentiation conditions). Cell/fibrin constructs were incubated with 
Annexin V (in green) and PI (in red), for detection of early apoptotic and dead cells, respectively. Nuclei were 
stained with Hoechst 33342 (in blue). Representative 2-D projections of CLSM stack images covering a depth of 
approximately 100 µm are presented. Scale Bar: 200 µm. (B and C) Percentage of apoptotic and dead cells, as 
assessed by image analysis of the 2-D projections of CLSM stacks. The results correspond to a single experiment 
(N=1). 
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Remyelination of CNS lesions associated with demyelinating disorders such as MS and SCI is still 
a challenging field. Natural remyelination mechanisms are not efficient in advanced stages of 
demyelination, eventually preventing neuronal function recovery. 
As previously referred, transplantation of OPCs has emerged as a feasible therapy to promote 
remyelination of spared and regenerating axons after CNS damage. The transplantation of OPCs in 
the form of cell suspensions presents drawbacks such as low cell survival and poor proliferation and 
differentiation, which are related with the lack of an adequate mechanical and biochemical support. 
As an attempt to overcome these limitations, the combination of cell transplantation with 
biomaterial-based matrices stands up as a promising solution namely by providing a supportive 
environment for transplanted OPCs to survive and differentiate. [8, 42] 
Although many hydrogels have been developed for cell delivery into the CNS, to date, only a few 
were explored for OPC delivery, among them, fibrin. [Li et al. (2013); Asmani et al. (2013)] In 
opposition to synthetic hydrogels, fibrin presents natural ligands for cell adhesion (two pairs of RGD 
sites and a pair of AGDV sites), proteolytic enzymes, growth factors, ECM proteins and protease 
inhibitors. 
OPCs and OLs express a limited repertoire of integrins, including the laminin receptor α6β1 
integrin, which has shown to enhance cell survival of myelinating oligodendrocytes and to promote 
myelination of axonal tracts in vivo 
[17,33,34]
. Although fibrin contains binding sequences for integrins 
αIIBβ3, αvβ3, αMβ2 and αxβ2, it does not present natural ligands for integrin α6β1 [68]. 
Therefore, the objective of this study was to assess OPC behavior in 3-D fibrin hydrogels 
containing covalently-bound α6β1 ligands. The functionalization of fibrin hydrogels with synthetic 
peptides with reported affinity for α6β1 integrin was expected to improve fibrin biospecificity 
towards OPCs, namely by promoting cell survival, process outgrowth and myelin membrane 
production in vitro, and ultimatly enhance cell survival of transplanted OPCs and theirability to 
remyelinate axons in vivo. 
Initially, different cells seeding densities (0.5 × 106 cells/mL, 0.75 × 106 cells/mL, 1 × 106 
cells/mL and 1.25 × 106 cells/mL) were tested for optimization of the cell seeding density in fibrin 
gels. A trend for the presence of cell clusters with radially-migrating OPCs and fibrin degradation 
halos was observed, with increasing cell seeding densities leading to the presence of more cell 
clusters. Besides presenting very few cell clusters when compared to hydrogels seeded with higher 
cell numbers, fibrin hydrogels seeded with 0.75 × 106 cells/mL also allowed a homogeneous cell 
distribution. Therefore, this cells seeding density was selected for further experiments. In addition, 
aprotinin (5 µg/mL) was shown to be required to avoid overall fibrin degradation. 
As cells can sense and respond to the biophysical properties of the microenvironment through 
mechanotransductional mechanisms, we subsequently assessed the effect of fibrinogen 
concentration on OPC cell viability and differentiation in 3-D fibrin gels. Process extension greatly 
varies throughout stages of differentiation from OPCs towards myelinating OLs, since it follows a 
stepwise morphological transformation. At the first stages of differentiation, OPCs present very few 
and longer processes. As they start to differentiate into late progenitors called pro-OLs, an 
increasing in the number of processes is observed. As these immature OLs evolve to mature OLs, 
they acquire a more complex structure, with a higher number of sprouting processes that are shorter 
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in length and start to present several branching points, giving these cells a starry-like morphology 
[85, 86]. With this in mind, a higher process number indicates that OPCs have differentiated into 
mature OLs, whereas a higher maximum length and average process length mean OPCs still at more 
immature differentiation stages. Therefore, to assess the effect of fibrinogen concentration on OPC 
differentiation in 3-D fibrin gels, gels with increasing fibrinogen concentrations (ranging from 2 to 8 
mg/mL) were prepared and the effect of fibrinogen concentration on cell viability and process 
extension evaluated. 
Results showed that OPCs were able to extend processes in all fibrin gels, independently from 
the concentration. Fibrin hydrogels gels prepared with the lowest fibrinogen concentration, 2 
mg/mL, revealed a higher degradation rate (even in the presence of 5 µg/mL aprotinin in the 
medium), which might explain the lower values obtained for the three parameters evaluated 
(process number, maximum length and average length) when compared to fibrin gels with 4 mg/mL 
of fibrinogen, since cells presenting well-developed processes had to be excluded from the analysis. 
Fibrin degradation rate is usually delayed by increasing the fibrinogen concentrations [65], which 
explains why fibrin gels prepared with 2 mg/mL of fibrinogen were more permissive to cell-secreted 
proteases. 
When a CNS-compatible hydrogel is being developed to be used as a cell carrier in the adult CNS, 
one may not forget to guarantee the mechanical compliance between the biomaterial and the native 
tissue. As already mentioned, the properties of fibrin hydrogels can be controlled either by 
fibrinogen or thrombin concentration, which affects the fibrin network structure and mechanical 
properties of the hydrogels. Typically, when the fibrinogen concentration is increased, resultant 
fibrin gels are dense and turbid, composed of thicker fibers. In addition, gel stiffness is also affected 
by fibrinogen concentration, usually with greater fibrinogen concentrations giving rise to stiffer 
matrices.[68] The mechanical properties of the fibrin gels used in the present study was previously 
characterized by Bento et al (2015, submitted) (Supplementary data – Appendix B). Since the 
average pore area (µm2) was higher for softer fibrin gels (4 mg/mL of fibrinogen) and diminished 
with the increase of fibrinogen concentration, it can be concluded that fibrin gels obtained from 
low fibrinogen concentrations are more permissive to cell infiltration. However, when fibrin gels are 
too soft, these may lack mechanical strength and robustness. In this sense, fibrin gels should be both 
permissive, allowing OPC infiltration and differentiation, but simultaneously ensure appropriate 
mechanical properties.  
When compared with gels prepared with the highest fibrinogen concentration tested (8 mg/mL) 
fibrin gels prepared with 4 and 6 mg/mL of fibrinogen led to a 1.8-fold and a 1.6-fold increase in 
the mean of the process number, respectively. The lower number of cell processes in fibrin gels 
prepared with 8 mg/mL may be related to the higher stiffness of these gels, which present higher 
storage modulus (G’) (G’= 1130.81 ± 46.10 Pa) when compared to fibrin gels with fibrinogen 
concentrations of 4 mg/mL (G’= 446.82 ± 50.51 Pa) and 6 mg/mL (G’= 786.86 ± 79.04 Pa), as reported 
by Bento et al (2015, submitted) (Supplementary data – Appendix B). Asmani et al. (2013) have 
already reported that cells respond to the mechanical properties of the environment. In this study, 
hydrogels with fibrinogen concentrations 2 mg/mL, 3 mg/mL and 4 mg/mL were compared regarding 
their mechanical properties. While fibrin gels prepared with 2 mg/mL and 3 mg/mL presented a 
storage modulus G’ < 1000 Pa, being suitable for both glial and neuron survival and proliferation, 
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gels prepared with 4 mg/mL of fibrinogen presented a G’ > 1000 Pa, being appropriate only for glial 
proliferation [66]. 
Even though the differences were not considered statistically significant, fibrin gels  prepared 
with 4 mg/mL of fibrinogen presented, in average, a higher number of processes per cell as well as 
higher maximum process length and average process length, when compared to those prepared with 
6 mg/mL of fibrinogen (7.0 ± 0.3 and 6.3 ± 0.7, respectively). Increasing the fibrinogen concentration 
to 8 mg/mL did not significantly impact the maximum process length or the average process length.  
Regarding OPC culture in 3D hydrogels, it was previously reported by Li X. et al. (2013) [65] that 
OPCs may exhibit a biphasic change in morphology over increasing elastic modulus of hydrogels. 
When cultured in hydrogels considered too soft, OPCs displayed round morphology, extending very 
few processes. In hydrogels of medium stiffness, OPCs were able to spread, resembling the natural 
morphology and behavior of OPCs in the body. However, as the hydrogel stiffness continued to be 
increased, cell spreading seemed to decrease, with OPCs assuming once again round morphology 
and even forming cell aggregates. [65] Thus, considering 4 mg/mL and 6 mg/mL fibrin hydrogels as 
mid stiffness matrices, it was expected that these fibrinogen concentrations would improve OPC 
process extension, when compared to stiffer matrices. When the fibrinogen concentration was 
increased for 8 mg/mL, OPCs started to present more round morphologies with few sprouting 
processes and started to be more aggregated, which was an expected result, since these hydrogels 
might be too stiff to allow OPC process extension. 
In addition to process outgrowth quantification, it was observed that the fibrinogen 
concentration did not significantly affect cell viability. Fibrin gels prepared with 4 mg/mL of 
fibrinogen presented the highest cell viability (74% of viable cells). In what concerns the lower values 
for cell viability compared to 2-D matrices, these can be explained by the fact that OPCs were 
cultured in 3-D fibrin hydrogels. When cultured in 2-D, dead cells eventually detach from the surface 
during medium replacement, whereas in 3-D hydrogels, cells, including non-viable cells, remain 
entrapped within the 3-Dfibrin network.  
Once better overall in vitro biological performance of OPCs in terms of process extension and 
cell viability was observed for fibrin gels prepared with 4 mg/mL of fibrinogen, this fibrinogen 
concentration was used for further functionalization studies. 
In order to enhance the biospecificity of fibrin hydrogels towards α6β1 integrin, these were 
functionalized with ligands specifically binding to this integrin: the T1 peptide of the angiogenic 
inducer CCN1, the HYD1 peptide and a combination of both peptides (HYD1+T1). Three peptide input 
concentration (5 µM, 10 µM and 20 µM), were investigated.  
The functionalization of fibrin gels with bi-domain peptides did not hinder the extension of cell 
processes, as shown by the CLSM analysis of cell/fibrin constructs previously processed for 
immunofluorescent labelling of α-tubulin and Olig2.  
Quantitative image analysis showed that the functionalization with HYD1, T1 or the combination 
of both bi-domain peptides was effective in promoting an increase in the number of cellular 
processes (1.4-fold increase vs unmodified gels for HYD1 and for the combination (HYD1+T1) and 
1.3-fold increase vs unmodified gels for T1 bi-domain peptide), already for the lowest peptide 
concentration tested (5 µM). Furthermore, functionalization with 5 µM of bi-domain peptides also 
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led to higher values of maximum length, although statistically significant differences in maximum 
length were not found. Even though, no additive/synergetic effect resulted from the combination 
of both bi-domain peptides, in terms of the mean of the process number and of the maximum process 
length (Fig. 18). Increasing the concentration of bi-domain peptides from 5 µM to 10 or 20 µM did 
not result in a significant increase of either the number of cellular processes or maximum process 
length, either when added separately or in combination. In terms of average length, no statistically 
significant differences were observed between functionalized gels (HYD1, T1 and HYD1+T1) and 
unmodified ones, independently of the input bi-domain peptide concentration. 
 While 5 µM of bi-domain peptides were already sufficient to promote OPC process extension in 
fibrin gels (4 mg/ml of fibrinogen), in case of embryonic stem (ES)-derived neural stem/progenitors, 
maximal outward migration in fibrin hydrogels (6 mg/mL of fibrinogen) was observed for peptide 
input concentrations of 20 and 40 µM of HYD1 and T1, respectively. [75] This difference may be 
associated with the decrease of peptide binding efficiency with increasing fibrinogen 
concentrations. Hall and Hubbell (2001) reported that the amount of incorporation of L1Ig6 (a ligand 
for αvβ3) depended on the fibrinogen concentration: in 2 mg/mL fibrin gels 72 ± 18% of the input 
iL1Ig6 was covalently incorporated, whereas in 4 mg/mL fibrin matrices the incorporation efficiency 
of iL1Ig6 decreased to 63 ± 8%. [87] The covalent binding of peptides to fibrin using the cross-linking 
action of factor XIIIa has been previously explored by Schense and Hubbell (1999), and is an effective 
approach for the binding of peptides with retention of biological activity. Based on this approach, 
as 4mg/mL of fibrinogen present a lankier and more porous structure, the ability of the bi-domain 
peptide to penetrate into the structure and bind to the polymerizing fibrin network through the 
factor XIIIa increases, thus allowing the attainment of higher amounts of immobilized peptides when 
compared with fibrin gels with 6 mg/mL of fibrinogen. The fact that an increasing trend in the 
process number was not observed when bi-domain peptide input concentrations were higher than 5 
µM may be related with an excess of peptide, which can lead to the saturation of α6β1 receptors in 
OLs, hindering the formation of new bindings. Consequently, the excess of bi-domain peptide would 
lose its ability to connect with OLs and the effect would no longer be felt by these cells. Hall and 
Hubbell (2001) have previously reported this effect by demonstrating that, among the iL1Ig6 (a 
fusion protein containing the transglutaminase Factor XIIIa-substrate sequence from α2-plasmin 
inhibitor at the N-terminus) concentration range tested (2.5, 1.2, 0.6, 0.3, and 0.15 µM), the 
covalent incorporation of iL1Ig6 was saturated at concentrations higher than 2.5 µM iL1Ig6. In fact, 
Schense and Hubbell (1999) have also reported maximal neurite extension (from E8 chicken dorsal 
root ganglia) for intermediate adhesion site densities and for higher densities neurite outgrowth 
inhibition, for fibrin gels functionalized with two adhesion domain bioactive sequences (RGD and 
DGEA. [88] 
After evaluating the sprouting ability of OPCs in functionalized fibrin hydrogels, their ability to 
differentiate into myelinating OLs was assessed. As previously mentioned, MBP is an 
oligodendrocyte-specific protein, located in myelin membranes, essential for OL morphogenesis at 
late stages of differentiation. Confocal analysis of cell/fibrin constructs processed for α-tubulin/MBP 
staining showed that OPCs cultured in 3-D fibrin hydrogels functionalized with HYD1, T1, or with 
both peptides, apart from being capable of extending processes, were also able to differentiate into 
myelinating OLs, independently from the bi-domain peptide concentration. Image analysis of InCell 
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Analyzer stack images will be performed in the near future, to quantitatively assess the effect of 
immobilized α6β1 ligands on MBP expression.  
Finally, since immobilized ligands should not compromise cell viability, OPC apoptosis was 
assessed. This assay was performed only in fibrin gels functionalized with 5 µM of bi -domain 
peptides, since higher peptide input concentrations did not result in significant improvement of OPC 
process outgrowth. Although results from a single experiment were reported, a low percentage of 
dead cells was observed in both functionalized and unmodified fibrin gels, except for (HYD1+T1)-
functionalized gels, in which 38% of dead cells was found. The high percentage of early apoptotic 
cells observed for both functionalized and unmodified gels (from 30 to 47 %) was associated to the 
3-D cell culture environment, which may have prevented the release apoptotic and dead cells from 
the gel along the cell culture period. Moreover, apoptotic phenomena are involved in differentiation 
transformations from OPCs to OLs, which may also explain the higher percentages of early apoptotic 
cells found. [89] Still, as only a single experiment was performed, further studies are necessary.
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5.1. Conclusion 
 
The objective of this work was to develop and hydrogel for delivery of OPCs into the CNS.  
For this purpose, fibrin hydrogels were functionalized with bi-domain peptides with reported 
affinity for α6β1 integrin. The functionalization with these synthetic ligands was expected to 
improve biospecificity towards OPCs by promoting process outgrowth and myelin membrane 
formation in vitro.  
 
The culture of OPCs in 3-D fibrin hydrogels was initially optimized in terms of cell seeding 
density and aprotinin concentration. A cell seeding density of 0.75 × 106 cells/mL allowed a 
homogenous distribution of OPCs in the hydrogel with few cell clusters, whereas 5 µg/mL of 
aprotinin were found to be sufficient to delay overall fibrin degradation while allowing fibrin 
local degradation by migrating cells and process extension. Varying the fibrinogen concentration 
did not significantly affect cell viability (in the range of concentrations tested, 2 - 8 mg/mL), 
although higher cell viability was attained for a 4 mg/mL fibrinogen concentration. Fibrinogen 
concentration was found to impact OPC differentiation, fibrin gels prepared with intermediate 
fibrinogen concentrations (4 mg/mL or 6 mg/mL) revealing the highest number of processes per 
cell, an indicator of differentiation. Since the fibrinogen concentration of 4 mg/mL showed a 
better overall biological performance, this was selected for use in functionalization studies. 
 
Functionalization with HYD1, T1 or the combination of both bi-domain peptides was 
successful in promoting an increase in the number of cellular processes, already for the lowest 
peptide concentration 5 µM. In addition, functionalization with 5 µM of bi-domain peptides also 
led to higher values of maximum length, although statistically significant differences in 
maximum length were not found. However, increasing the bi-domain peptide concentration in 
fibrin gels from 5 µM to 10 µM or 20 µM did not result into an increase in process extension. In 
addition, no additive/synergetic effect was observed when fibrin gels were functionalized with 
a combination of HYD1 with T1 instead of HYD1 and T1 alone.  
 
Functionalization with α6β1 ligands did not hinder OPC differentiation into myelin-
producing OLs. Myelin production by OLs was observed for all HYD1-, T1-, and (HYD1+T1)-
functionalized gels, independently of the bi-domain peptide concentration. Apoptosis has 
shown a high percentage of apoptotic cells for all the conditions tested, with HYD1 peptide 
showing the lowest percentage of apoptotic cells. Results from a single apoptotic assay 
performed after 9 days of cell culture showed similar percentages of early apoptotic cells for 
both functionalized and unmodified gels, as well as similar fractions of dead cells, except for 
fibrin gels functionalized with both the bi-domain peptides. 
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5.2. Future perspectives 
 
Taking into consideration the results obtained in this study, future studies are needed not only 
to increase the robustness of the results obtained, but also to get insight into the effect of 
immobilized HYD1 and T1 bi-domain peptides on other parameters of OPC behavior in 3-D fibrin 
hydrogels.  
Although significant differences were already obtained using 47-60 cells in the quantitative 
analysis of process outgrowth, this analysis will benefit from increasing the number of cells analyzed 
in each independent experiment to 100 cells, to increase the robustness of the results. In addition, 
other process outgrowth parameters should be assessed, namely primary and secondary branching 
points, as these can be associated to different stages of OL development. 
The percentage of MBP+ cells expressing Olig2 should also be quantitatively analyzed to assess 
the effect of the functionalization in OPC differentiation and myelin production.  
Cell viability should be performed also in functionalized fibrin gels, to ensure these can be used 
as a safe platform for OPC survival and differentiation. In addition, cell viability could be assessed 
at other timepoints, for example at day 5 and day 7 of culture, since OPC viability was reported to 
decrease with time in 3D fibrin hydrogels by Asmani et al (2013). Also, apoptosis should be assessed 
to accomplish a total of 3 independent experiments, to obtain more consistent results. 
Finally, since significant increase in the number of processes per cell was already found for the 
lowest bi-domain peptide concentration, fibrin gels with input concentrations of bi-domain peptides 
lower than 5 µM should be prepared and their effect on OPC behavior evaluated. 
Present results indicate that fibrin gels functionalized with α6β1 ligands are interesting for OPC 
culture in a 3-D environment and potentially promising for OPC transplantation in an in vivo scenario. 
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Figure A1. Quantitative analysis of process outgrowth of OPCs cultured in fibrin hydrogels, as a function 
of fibrinogen concentration. Cell/fibrin constructs were cultured for 9 days (2 days under proliferation 
conditions and 7 days under differentiation conditions), and subsequently processed for 
immunofluorescent labelling of α-tubulin and olig2. Process outgrowth was determined in InCell Analyzer 
stack images of cell/fibrin constructs covering a depth of approximately 200 µm, by image analysis. Only 
cells expressing olig2 were considered for the analysis. To evaluate process extension three parameters 
were considered: (A) Process number per cell; (B) Maximum length; (C) Average Length. In each 
experiment, 45-60 cells were analysed in two replicate cultures. Results pooled from three independent 
experiments are shown ( *, p < 0.05; **, p < 0.01; ***, p < 0.005, as assessed using the Kruskal-Wallis non-
parametric test followed by Mann-Whitney U test ).  
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Appendix B 
 
 
Figure B1. Effect of fibrinogen concentration on Fb hydrogels microstructure and stiffness. (A) 
M icrostructure of Fb gels prepared with 4, 6, 8 or 10 mg/mL of fibrinogen spiked with Alexa Fluor 488-
labeled fibrinogen. Representative 2-D projections of CLSM stack images covering a depth of 10 µm are 
shown. (B) Average pore area of Fb hydrogels, as determined by image analysis of the 2-D projected CLSM 
stacks (N = 4; *, p < 0.05). (C) Storage modulus (G’) and loss modulus (G’’) of Fb hydrogels, as assessed 
by rheological analysis (N = 6 independent experiments; *, p < 0.05; **, p < 0.01; ***, p < 0.005). (Bento 
et al., 2015, submitted) 
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Figure C1. Immunocytochemistry analysis of OPC process extension in 4 mg/mL fibrin hydrogels 
functionalized with HYD1 bi-domain peptide as a function of peptide input concentration in polymerizing 
gels. Cell/fibrin constructs were cultured for 5 days (2 days under proliferation conditions and 3 days 
under differentiation conditions) and subsequently processed for immunofluorescent labelling of α-tubulin 
(in green)/olig2 (in red). Representative 2-D projections of split CLSM stack images of cell/fibrin 
constructs covering a depth of approximately 30 µm are presented. Scale Bar: 50 µm. 
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Figure D1.  Immunocytochemistry analysis of OPC process extension in 4 mg/mL fibrin hydrogels 
functionalized with T1 peptide as a function of peptide input concentration in polymerizing gels. 
Cell/fibrin constructs were cultured for 5 days (2 days under proliferation conditions and 3 days under 
differentiation conditions) and subsequently processed for immunofluorescent labelling of α-tubulin (in 
green)/olig2 (in red). Representative 2-D projections of split CLSM stack images of cell/fibrin constructs 
covering a depth of approximately 30 µm are presented. Scale Bar: 50 µm. 
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Figure E1.  Immunocytochemistry analysis of OPC process extension in 4 mg/mL fibrin hydrogels 
functionalized with HYD1+T1 peptides as a function of peptide input concentration in polymerizing gels. 
Cell/fibrin constructs were cultured for 5 days (2 days under proliferation conditions and 3 days under 
differentiation conditions) and subsequently processed for immunofluorescent labelling of α-tubulin (in 
green)/olig2 (in red). Representative 2-D projections of split CLSM stack images of cell/fibrin constructs 
covering a depth of approximately 30 µm are presented. Scale Bar: 50 µm.  
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Figure F1. Process outgrowth quantitative analysis of OPCs cultured in fibrin hydrogels (4 mg/mL of fibrinogen) 
functionalized with bi-domain peptides, as a function of peptide input concentration in polymerizing gels: (A) HYD1; 
(B) T1 and (C) HYD1+T1. Cell/fibrin constructs were cultured for 5 days (2 days under proliferation conditions and 3 
days under differentiation conditions), as assessed by image analysis of InCell Analyzer z-stacks covering a depth of 
approximately 200 µm. To evaluate process extension three parameters were considered: (A) Mean process number; 
(B) Mean maximum length; (C) Mean average length. In each experiment, 45-60 cells were analyzed in two replicate 
cultures. Results from three independent experiments are shown. Process outgrowth in functionalized fibrin 
hydrogels was compared to that in unmodified gels (*, p < 0.05; **, p < 0.01; ***, p < 0.005).  
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Figure F2. Process outgrowth quantification of OPCs cultured in 4 mg/mL fibrin hydrogels functionalized 
with 5 µM of bi-domain peptides (HYD1, T1 and HYD1+T1). Cell/fibrin constructs were cultured for 5 days 
(2 days under proliferation conditions and 3 days under differentiation conditions), as assessed by image 
analysis of InCell Analyzer z-stacks covering a depth of approximately 200 µm. Three parameters were 
considered to evaluate process extension: (A) Process number; (B) Maximum length; (C) Average Length. 
Results from three independent experiments are shown. In each experiment, 45-60 cells were analyzed 
in two replicate cultures. Results were not considered statistically different as assessed by Kruskal-Wallis 
non-parametric test. 
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Figure G1. Immunocytochemistry analysis of OL myelin production in 4 mg/mL fibrin hydrogels 
functionalized with bi-domain peptides (HYD1, T1 and HYD1+T1), as a function of peptide input 
concentration in polymerizing gels. Cell/fibrin constructs were cultured for 5 days, 2 days under 
proliferation and 3 days under differentiation conditions. Representative 2-D projections of MBP channel 
(green) of CLSM stack images of cell/fibrin constructs covering a depth of approximately 30 µm are shown. 
Scale Bar: 50 µm. 
 
